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1. INTRODUCTION 
Siddha System of Medicine is believed to be originated from lord shiva the 
supreme god of Tamil and also he is considered to be the principal siddhar.  Lord 
shiva preached this grateful science to shakthi, the goddess and the nanthi from them 
the siddha system was made available to common people by siddhars. 
Siddhars were those who were not only a physican but also social reformers. 
They were well versed in the field of medicine, natural science, alchemy, astrology, 
etc. Siddhars were the persons who attained siddhi, that perfection and who had 
overcome death through these siddha Medicines.  
 They give many excellent medicines which cure many challengeable diseases 
like diabetes, TB, HIV & Cancer. 
It is estimated that at some point during lifetime approximately 39.6% of 
women and men will be diagnosed of cancer. In India, it is estimated that14.5 lakh 
people are living with the disease, with over 7 lakh new cases being registered every 
year and 5,56,400 deaths which are said to be cancer related. An estimated 71% of 
cancer related deaths are occurring in the age group between 30 and 69 years
[1]
. 
As rights said in this modern world the air we breathe, the food we eat and our 
life styles are all carcinogenic and are ultimately leading us by one way or other to 
dreadful disease cancer. Everyone in this world rich or poor, men or   woman, young 
or old, and even animals or prone to affect by this disease and that could be 
prophylatically given against this disease. Also there is no medicine in the world that 
good completely cure this disease. 
The Currently available treatments for Cancer viz Radiation, Chemotherapy 
and Surgery are all of very Limited Value. The Surgical Procedures are useful only is 
very early stage and it is miserable that the disease is often detected in advanced 
stage.  The Radiation technique and Chemotherapy are useful only to prolong the 
survival period
[2]
. 
In the pathetic Situation when scientist all over the world struggling to 
formulate a new medicine to combat the disease. In our Siddha system of medicine 
we had thousands of medicine with the indications to cure the disease. 
Among various medicine mentioned to treat cancer  in Siddha literature.  Rasa 
Karpoora Kuligai is one of the Siddha herbomineral formulation mentioned  to treat 
various type of cancer
[3]
. Rasa Karpoora kuligai shows significant  anti oxidant and 
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anticancer effect against HeLa cell lines studied by in vitro (V.Manjari,et.al 
,2016,WJPR,Vol-v,Issue-9). The safety profile of Rasa Karpoora Kuligai is not 
scientifically validated. The author selected and Studied the safety profile of  Rasa 
Karpoora Kuligai through acute  and 28 days repeated oral toxicity studies as per 
OECD guideline 423 and 407
[4].
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2. AIM & OBJECTIVES 
TITLE OF RESEARCH:  Preclinical Safety Evaluavation of “Rasa Karpoora 
Kuligai” 
2.1. AIM: 
                  To evaluate the safety profile of (Acute and 28days Repeated dose oral 
Toxicity study) “Rasa karpoora kuligai” in Wistar albino rats. 
2.2. OBJECTIVES: 
 Collect the literature  review of  ingredients of  Rasa karpoora kuligai 
 Purification and preparation of the Medicine as per literature 
 To study the quality parameters for “Rasa karpoora kuligai”. 
 Acute oral toxicity study & 28days repeated oral toxicity study of 
“Rasa karpoora kuligai “as per OECD Guideline 423 & 407. 
 Evaluation of  safety of the study drug  
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3. REVIEW OF THE LITERATURE 
3.1. RASA KARPOORAM (இரச கற்பூரம்) 
3.1.1 GUNAPADAM ASPECT 
Rasakarpooram does not find a place in the list of 64 padanas but it is one 
of the Pancha sootham. It’s prepared by the combination of rasam and salt[3]. 
 
SYNONYMS: 
“துர்க்ககககையெலிெிகைச்சனிபூரந் 
தீட்டுவிைதாலிநக்கிபூடிமதாந்” 
- நாமதீபநிகண்டு 29[5] 
 Durgai 
 Kalai 
 Aellidai 
 Sani 
 Pooram 
 Thettu 
 Vidathaali 
 Nacki 
 Buddimaatham  
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RASA KARPOORA VAIPU MURAI: (Method of preparation) 
METHOD I: 
 “தாயனன்றகற்பூரயமான்றுயசால்வவன் 
  சாதகமாய்சூதம்யரண்டுதூக்கி 
 வாயனன்றசட்டிக்குள்மூன்றுபடியுப்கப 
  வைமாகயபாடித்திட்டுநடுவவவகளு 
 வதயனன்றயசங்கல்தூள்கால்படிதானிட்டு 
  திரமாகக்குைித்ததிவலசூதம்விட்டு 
 ஏயனன்றமறுசட்டிகவிழ்த்துமூடி 
  இெல்பாகயவழுசீகலமண்ணும்யசய்வெ 
 மண்யசய்துயதாண்ணூறுகடிககெப்பா 
  வாகாகமூத்தீயுயமரித்துகமந்தா 
 மண்யசய்தவமல்சட்டிக்குள்வைவகளு 
  வாகாகஉகரத்திருக்கும்யவள்கையமதத் 
 மண்யசய்தநற்பூரங்குழாெில்கவத்து 
  வாகாகபணவிகைதான்தூக்கிக்யகாண்டு” 
- Agasthiyar paripooranam 400[6]. 
2 palam sootham will be placed in the mud pot in between 3 padi culinary 
salt(Nacl) and brick stone powder. Close the pot with another mud pot and seal with 
clay plaster 7 times (man seelai). It will be burnt for 90 kadikai burn time after that 
cooled pooram was found deposited on the upper pot and the same was collected. 
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METHOD II: 
மெக்கமுறுமிரதகற்பூரஞ்யசால்வவாம் 
விொதியெல்லாந்தீர்ந்துவபாம்வரிகசவகளு 
மெக்கமுறஉப்புளுக்குச்யசங்கல்தூளும் 
வரிகசயபறவழித்யதடுத்துகவத்திைாவெ 
கவத்தவதார்இருவககயுந்தூைாொட்டி 
கமந்தவனசட்டிக்குள்பாதிநீயும் 
கவத்திடுவாய்அதிற்குகககெச்சூதமப்பா 
வாராைாகழஞ்சுபத்துமாற்றமன்றி 
கவத்தங்வககுககவாெில்யபாடியுமிட்டு 
மறுசட்டியகாண்டிட்டுவாகெமூடி 
கவத்துநீவெழுசீகலமண்ணும்பூசி 
 மாெிபதம்பூசித்துஅடுப்பிவலற்றி 
அடுப்வபற்றிகமலவன்னிதினந்தாயனான்று 
 அதன்பிறகுகைாக்கினியுந்தான்மூன்று 
எரித்தாறியெடுத்துப்பார்சட்டிவமவல 
 ஏறிநிற்கும்கற்பூரம்எடுத்துகவத்து[5] 
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10 kalanju of sootham placed in mud pot in between the well powdered 
culinary salt and brickstone powder. Then close the mud pot with other mud pot then 
surmounted. The whole set up is burn as deepackini kamalackini and kaadackini for 3 
days respectively. After it is cooled with the 7 times of clay plaster. The pooram was 
found deposited on the upper pot and the same is collected. 
METHOD III: 
Sulphur 67.2gm is melted in mud pot and mercury 336gm is added to it and 
grinded well and there forms a black coloured powder (kajali). Brickstone powder is 
placed up to half of the level of a pot culinary salt (Nacl) 650 gm is placed over it. 
Mercury sulfer camphor is placed over the salt and sealed with mud paste cloth. It 
burnt for 12 hours with kadackini after it is cooled the pooram (mercurous chloride) is 
found deposited on the upper pot and the same is collected. 
OTHER CANCER MEDICINES WHICH CONTAIN RASA KARPOORAM AS 
CHIEF INGREDIENT: 
1. CHANDA MAARUTHA CHENDOORAM: 
Dosage    :  ½ - 1 kundri 
Adjuvent    :   palm jaggary, tripala legium, panjadepakkini  
legium. 
Indication   :  Aruvagai putru (six types of cancer) 
Pavuthiram (fistula) 
Paarisavaayu (hemiplegia) 
        Mugavadham (facial palsy) 
2. VAAYU MAATHIRAI: 
Dosage   :   ½-1 maathirai 
Adjuvent   :  Palm jaggary, sukku paste. 
Indication   :   Uterine cancer (Allgul putru) 
        Penial cancer (Linga putru) 
        Necrotic ulcer (Ali ranam) 
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3. CHITHIRAMOOLA KULIGAI: 
Dosage  :  1 Melagu 
Adjuvent  :  Palm jaggery 
Indication  :  Uterine cancer (Yoni putru),  
Penile cancer (Linga putru),  
8 types of ulcers (Gunmam).      
4. KOOROSANAI  MEZHUGU: 
Dosage   :  3-5 kundri 
Adjuvantent   :  Sugar, palm jaggery 
Indication   :   Uterine cancer (allkul putru) 
Syphilis (kiranthi) 
Amenorrhoea (soodaka kattu) 
5. POORA KATTU 
Dosage   :  1-4 rice weight 
Adjuvantent  :  parangipattai legium, vaalmilaggu legium. 
Indication  :  Uterine cancer (allgul putru) 
Syphilis (Meganoi) 
Urinary bladder ulcer (neerpai ranam) 
6. VETTAI MEZHUGU: 
Dosage  :  1/2 – 1 kundri 
Adjuvantent  :  palm jaggery, butter 
Indication  :  vettai (venelial diseases) 
Aan kurri pan (penear ulcer) 
Neerthaarai pun (ureter ulcer) 
 
PROPERTIES: 
Colour  - White 
Appearance - Heavy white rhombic crystals 
Potency - Hot 
Taste  - Salty, Pungent 
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ACTION: 
 Laxative 
 Tonic 
 Antiseptic 
 Diuretic 
It is also an after excessive bile producer. 
 
 
THERAPEUTIC EFFECTS: 
“இகைவாதசூகலயெரிசூகலகுன்மந் 
யதாகைவாகழவாதமாஞ்வசாணி – ெிகைொவதா 
யவாக்குரசகர்ப்பூரயமான்வறெனயவாருதல் 
இக்குயவல்லத்வதழுநாை“ீ. 
When calomel is taken along with jaggery for seven days, 
  It cures various types of throbbing pains,  
 Throbbing pain in the lumbar region, 
 Burning sensation, 
 Ulcer due to disorders of vatha humours[7], 
In siddha system of medicine his compare to sanjeevi because it cures disease 
like syphilis(kiranthi), vulvar cancer (allgul putru), vulvar ulcer (allgul ranam) and 
chronic non-healing ulcers. 
- AVN 4th vol  
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PURIFICATION OF CALOMEL: 
METHOD I: 
The poultice made of betel leaf (piper betel) and pepper (piper nigram) each 
8.75gm, is taken and dissolved in 1.3 litre of water. Take 35gm of calomel and tied 
with a cloth and immersed in the above liquid from the crops bar and heated. When 
water is reduced to ¾ of its volume the calomel is taken out washed with water and 
allowed to dry under sunlight
[3]
. 
METHOD II: 
35 gm of Calomel is consolidified in mother’s milk for 3 hours and again it is 
consolidified in garlic oil(thailam) for 9 hours
[3]
.  
 
SIGNS AND SYMPTOMS OF CALOMEL POISONING: 
Medicine prepared from not properly purified calomel will cause Multiple red 
boils on the face, ache formation, ulcers in the chest, mouth and tongue, diarrhoea and 
dysentery, scrotal swelling and ulcer in the vulva.   
ANTIDOTE FOR POISONING: 
Nilapanai kilangu (Curculigo orchides)      -  8.75gm 
Vallarai ver (Centella asiatica root)            -  8.75gm 
Ponnankanni ver (Alternatheria sessiles)       -  8.75gm 
Kanduparangi ver (Clerodendrumserratum)   -  8.75gm  
All the above ingredients are mixed and boiled to make a decoction.  This 
decoction is used twice a day for two or three weeks with suitable diet restrictions. 
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3.1.2 GEOLOGICAL ASPECT 
MERCURY SUBCHLORIDE: 
 Mercury sub chloride is a chemical compound with the formula Hg2cl2. Also 
known as calomel (a mineral form rarely found in nature) 
 
IUPAC name   :   Dimercury dichloride 
Other name    :   Mercurous chloride 
Calomel 
Horn mercury 
Mercury (I) chloride 
Chemical formula  :  Hg2cl2 
Molar mass    :   472.09 g/mol 
Appearance    :   Heavy white rhombic crystals 
Density    :   7.150 g/cm
3
 
Melting point    :   525°c 
Boiling point    :   383 °c 
Solubility in water   :   0.2 mg/100ml 
Solubility    :   Insoluble in ethanol, ether 
Refractive index   :   1.973
[8] 
LD50 median dose   :   210 mg/kg (rat, oral) 
 
OCCURRENCE: 
 Haria,  
 Obermoscuel,  
 Armaden in Spain  
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PREPARATION OF MERCUROUS CHLORIDE: 
It is the most important mercurous compound.  In nature it occurs as horn 
quick silver. It is prepared by 
1. HgSo4 + 2Nacl +Hg → Hg2cl2 + Na2So4 
Subliming a mixture of mercuric sulphate, mercury and sodium chloride in 
iron pot 
2.  Hgcl2 + Hg
∆
→Hg2cl2 
By heating an intimate mixture of Hg2cl2 and Hg in appropriate mixture 
proportions in iron pot. 
3.  Hg2 (NO3) + Nacl →Hg2cl2 + 2 NaNo3 
Hg2 (NO3) + 2Hcl →Hg2cl2 + 2HNO3 
By adding a soluble chloride, Eg: Nacl or dill Hcl to the solution of Hg(NO3). 
4.  2Hgcl2 + 2H2O + SO2→Hg2cl2 + 2Hcl + 2H2SO4 
By reducing Hgcl2 solution with SO2
[8] 
 
ACTION: 
 Cathartic 
 Alterative 
 Diuretic  
 Antiseptic  
 Anthelmintic. 
INTERNAL USES: 
 Constipation,  
 Cholera,  
 Dysentery,  
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 Cardiac dropsy, 
 Pleurisy,  
 Malign fever 
 Malaria,  
 Syphilis, 
 Gout, 
 Worms, 
 Cholelithiasis, 
 Mitral insufficiency, 
 Eclampsia,  
 Gravidorum. 
EXTERNAL USES: 
 Small pox pitting, 
 Pruritus, 
 Diphtheria,  
 Syphilitic ulcer, 
 Myiasis, 
 Membrane croap, 
 Condylomata warts[9] 
3.1.3 USAGE OF CALOMEL IN VARIOUS ASPECTS 
Calomel was a mercurial compound used extensively by both union 
confederate doctors to treat wide variety of medical conditions. It came in two main 
forums. “Blue Pills” contained a mixture of mercury rose water, licorice, powdered 
rose, honey and sugar. “Blue Mass” was a lump of Mercurous chloride from which 
dispensing doctors pinched of a place. Doses were never standard. 
14 
 
In 19
th
 century doctors feared constipation and dispensing calomel was one 
of the main methods of keeping the bowl open. However, strangely enough, calomel 
was also given to treat diarrhoea and dysentery. Many physicians seemed unaware 
that the doses of calomel and a related compound, tartar emetic, often caused worse 
problems that the original conditions. 
The large and frequent doses of mercury compounds cause excessive 
salivation often a pint to a quart a day. Many patients receiving these “heroic” doses, 
suffered from mercurial gangrene death of cheek and mouth tissue that often led to 
permanent facial deformities. Lose and lost teeth were common, as was death from 
mercury poisoning. 
In 16
th
 century paracelsian and china physicians are used to treat malaria and 
yellow fever and a preparation called “worm chocolate” and “worm candy” was given 
to patients infested with helminthis. 
Toxic effects were soon noticed in individuals given large doses for long 
periods, in which excessive salivation, gum inflammation, loosening of teeth, gastro-
intestinal upset and an ashen appearance developed. They had troubling neurological 
symptom, such as arm and facial tremors, hyperfine, ataxia and erethism, unusual 
timidity and personality change. 
The toxic potential of calomel was highlighted in 1948. A Cincinnati 
paediatrician discovered that a common infantile and childhood illness called 
“Aerodynia” or “Pink disease” was caused by the white spread use of calomel in 
treating childhood teething and constipation. As late as 1950 acrodynia accounted for 
more than 3% of admissions to children ward’s in London hospitals. Official statistics 
record that 585 children died of pink disease between 1939 and 1948 in England and 
waves
[10]
.   
15 
 
 “Effect of dose not in proportion to size” well – triturated doses better than 
large coarse one. 
3.2ALLIUM SATIVUM –யவள்கைப்பூண்டு 
3.2.1 GUNAPADAM ASPECT 
VELLAIPUNDU SYNONYMS: 
nts;Ss;sp jd;Dila tptuq;NfS 
Nkjpdpf;Fiw Nrhdh yR Nehyp\;Nlhk; 
ks;Ss;sp kJrpa nfe;jhq; Nfs; m];jkhk; 
kfhfe;Njha;Nfh Neu; epahF fpuQ;rNdh 
ks;Ss;sp jPgj;jpuf;fkhFQ;  
nrg;gpaNjhu; nts;Ss;sp;r; nraYkhNk. 
 Bogar nigandu 1200 
SYNONYMS: 
 Kuraisonalasu 
 Nolistoo 
 Madhusiya kaentharam  
 Kael astham 
 Maha kanthoo  
 Koonaerniyaa 
 Kiranchunoovaa 
 Kaayam 
 Ulli 
 Pundu 
 Vellai pundu  
 Velvengayam 
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VERNACULAR NAME 
Eng  :  garlic 
Tel  :  thella, gadda , velulli 
Mar  : lohson 
Mal  : vellulli 
Kan  : bellulli 
Sans  : lasuna 
Hind  : lashan 
HABITAT: 
It is cultivated all over India. It is more pungent than onion. Nilakiri pundu is 
more popular. 
PARTS USED: 
Bulb and oil. 
 
ORGANOLEPTIC CHARACTERS: 
Colour            -         White 
Odour  - Garlic Odour 
Taste  - Pungent (karppu) 
Character - Veppam 
Pirivu       - Pungent
[11] 
- Gunapadam Mooligai Vaguppu 
CHARACTERS: 
Taste - pungent, 
Potency Character-Hot potency 
Biotransformation-pungent
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GENERAL CHARACTERS: 
 Garlic used for deafness chronic cough, asthma dysentery, headache, 
cyanicites, haemmoroids. 
 It also used for vadha diseases, kapha headache and oral diseases. 
 Garlic taken along with pepper and karichallai for stomach problems 
 1 to 2 drops of garlic juice droped into ear for ear diseases and deafness 
 garlic juice processed along with gingelly oil and used for ear diseases 
 20 to30 drops of garlic juice used 2 to 3 times per a day for chronic cough, 
asthma. 
 Garlic juice processed with mustard or coconut oil then it is externally used for 
body pain, pricking pain, whezzing, vadha diseases. 
 
ACTIONS: 
 Carminative,  
 Stimulant, 
  Expectorant, 
 Anthelminthic, 
 Anti oxidant, 
 Stomachic, 
  Tonic, 
 Alterative, 
 Diuretic[11]. 
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MEDICINAL USES: 
 Clove of garlic was known as a home remedy in olden days in the east and is one 
of the most useful on account of it s prophylactic and curative properties. 
 The garlic oil capsules product the human body from the attacks of bacteria and 
bacillae in times of epidemics or when the danger of infection is prevalent and 
containing all the curative properties. 
 These capsules renew the blood cleanse if of all impurities regulate the digestion 
and remove all parasites in the intestines which might be injurious to health  
 The capsules recommended for diseases of the lungs arterio-sclerosis high blood 
pressure, gout, rheumatism, asthma, chronic bronchial catarrh, intestinal 
complaints, loss of appetite, constipation and worms. 
 The oil from seeds is prescribed internally as a febrifuge to prevent recurrence of 
the cold fits of intermittent fever  
 Externally it is used in paralytic and rheumatic affections as resolvent the garlic is 
applied to indolent tumours. 
 Internally garlic given with common salt in affection of the nervous system 
headache flatulence hysteria cough etc. 
 In emergency conditions it is applied like onion to the nose in cases of fainting  
 Externally the juice used as a rubefacient, liniment acts very beneficially in 
infantile convulsions other nervous and spasmodic affections relax sore throat in 
asthma, general paralysis, facial paralysis, gout and sciatica  
 It is used for skin diseases including leprosy.  
 When eaten in cold season it is said to ward off attacks of rheumatism and 
neuralgia  
 Garlic produce copious dieresis and therefore it is used in dropsy and anasarca 
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 Garlic juice mixed with 3-4parts of ordinary or distilled water has been used as a 
lotion for washing wounds and foul ulcers
[11]
 
 
OTHER SIDDHA FORMULATIONS: 
1. KAALAMEGA NARAYANA CHENDOORAM: 
Dosage : 30-100mg 
Adjuvant : Thippili powder 
 Indications : Uterine cancer, Cheek cancer 
2. THAMIRA CHENDOORAM: 
Dosage : 30-45mg 
Adjuvant : Garlic juice 
Indications : Weakness 
3. PANCHA SOODHA MELUGU: 
Dosage : 50-100mg 
Adjuvant : Garlic juice 
Indications : Vadha diseases, five types of pain 
4. PASAANA PARPAM: 
Dosage : 1 milagalavu 
Adjuvant : Garlic juice 
Indications : Many diseases 
5. KANTHAGA MELUGU: 
Dosage : 2-3 Kundri 
Adjuvant : Garlic juice 
Indications : Leprosy, Diabetes insipidus
[12] 
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3.2.2. BOTANICAL ASPECTS: 
ALLIUM SATIVUM 
Taxonomy Classification 
Kingdom : Plantae 
Division : Angiosperms 
Class  : Monocots 
Order  : Asparagales 
Family  : Amaryllidaecae 
Subfamily : Allioideae 
Genus  : Allium 
Species : A.sativum 
 
Vernacular name 
Eng  : Allium sativum 
Sans  : Lacuna, Ugragandua, Bhutagua, Mahusudra, Rosanam 
Hind&Bom : Lasan 
Sind  : Thum 
Per  : Sir 
Gug  : Lasan, Shutam 
Mah  : Lasan 
Tel  : Vellulli, Tellagadda 
Tam  : Vellapundu, Vallai Pundu, Ulli Pundu 
Mal  : Vellulli 
Can  : Bellulli 
Ben  : Rasan
[11]
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Parts used:  
Bulb  
Distribution: 
 Garlic is among the oldest knowing horticultural crop.  In the old world 
Egyptian and Indian cultures referred to garlic 1000 years ago and there is clear 
historical evidence for it use by the Barsilonians 4500 years ago. 
 Garlic grows wild only in Central Asia (Centered in Kyrgyzstan) today. 
Earlier in history garlic grew wild over a much larger region and, in fact, wild garlic 
may have occurred in an area from china to India to Egypt to the Ukraine.  It’s 
cultivated all over the world in Spain, France, Egypt, Bulgaria, Hungary, USA, 
Mexico and Brazil. 
HABITAT: 
 Garlic is perennial of the lily family. It grows to a height of about 60 cm. It 
has short, flat upright leaves 15-30cm. The tall single flower stem bears spherical 
head of pale pink or greenish- white blooms often mixed with tiny bulbis the 
subterranean white-skinned bulb or corn is subdivided into numerous “cloves”[13]. 
ACTION: 
 Hot, 
 Stimulant, 
 Carminative,  
 Emmenagogue,  
 Antirheumatic,  
 Anthelmintic, 
 Alterative[11]. 
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Organoleptic properties: 
 The bulbs are pinkish-white colour and are odoriferous. The size of the bulb 
varies in between 1.5-2.5 cm. 
Morphology \Macroscopical Characters: 
 The bulb grows at the base of a perennial plant with an erect 
flowering stem that grows 2-3 ff long. 
 The bulb is made up of several outer thin protective sheaths 
covering the inner sheathes.  The inner sheath covers the swollen 
leaves called as cloves. The mature bulb has around or more cloves 
in each bulb. 
 The cloves gave no symmetry except for a few present in the 
centre. 
Microscopic characters: 
The bulbs are covered by an outer scale.  The outers scale is made up of an 
epidermis which encloses a mesophyll (devoid of chlorophyll), a ground tissue and 
below it is a layer of lower epidermal cells. 
The dry scales also contain about 2-3 layers of rectangular cells. 
The rectangular cells may have many rhomboidal crystals of calcium oxalate 
The epidermal cells contain parenchymatous cells connected to several 
rectangular cells and vascular bundles made up of alternating xylem and phloem. 
The epidermal cells contain thick pitted walls. 
The lower epidermis consists of smaller rectangular cubical cells
[14]
. 
Phytochemistry: 
Garlic bulbs are made up of numerous minerals, vitamins, carbohydrate, 
amino acids, volatile oils and other trace elements. 
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Amongst all the members of the Allium species, garlic is said to have to the 
highest sulphur content. 
Volatile oils are present in about 0.1-0.5% concentration in garlic. These 
constitute of sulphur containing compounds like diallyl sulphide, diallyl trisulphide, 
methyl allyl sulphide, allyl propyl disulphide, allin, ajoene etc. 
When the garlic clove is crushed allin (s-allyl-1-cysteine sulpoxide) by the 
action of the enzyme allinase gets converted to 2-propene-2-sulfenic acid which in 
turn dimerizes to allicin (diallyl thio sulfinate) 
Allicin is responsible for the pungent odour of crushed garlic and also for zone 
of its pharmacological activities of garlic. 
Vitamins like vitB, VitA, VitC etc, 17 amino acids including 8 essential amino 
acids and minerals like Phosphorus, Calcium, Magnesium, Potassium, Iron, Selenium, 
Germanium etc are present
[15]
. 
Garlic medicinal uses 
In Hypercholesterolemia– Garlic has said to lower cholesterol levels. The 
proposed mechanism for this is that the diallyl disulphides and diallyl trisulphides 
present in garlic oil interfere with the factors normally responsible for lipid synthesis. 
Garlic can reduce the activity of the thiol group in the enzymes in the body. Garlic oil 
can also carry out oxidation of NADPH. Thus, both the above activities interfere with 
normal lipid synthesis and blood lipid levels are reduced. These thiol containing 
enzymes are HMG-CoA reductase and coenzyme A which are essential enzymes for 
cholesterol biosynthesis. 
Other proposed mechanisms for reducing lipid levels are increased loss of bile 
salts in the feces. It has also been suggested that mobilization of these lipids into 
circulation can also reduce lipid levels. 
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As Antithrombotic agent– Ajoene (4, 5, 9-trithiadodeca-1, 6, 11-triene-9-
oxide) present in garlic is considered to inhibit platelet aggregation and is the most 
potent antithrombotic component of garlic. Methylallyltrisulphide present also acts 
as an antithrombotic agent. The suggested mechanism for this is the interference with 
thromboxane synthesis. 
It also shows fibrinolytic properties thereby helping in clot degradation. 
Antimicrobial properties– Garlic shows antimicrobial activity against 
various pathogens such as bacteria including resistant types, fungi, virus etc. It is 
active against both gram positive and gram-negative bacteria and strains of 
Mycobacterium. These effects are seen due to ajoene present in garlic. Allicin also 
shows the antimicrobial properties by inhibiting thiol containing enzymes thereby 
affecting protein, DNA, RNA synthesis. 
Due to the antifungal properties, garlic has been proposed for the treatment of 
oral and vaginal candidiasis. 
Garlic is active against various viruses such as herpes simplex virus type I and 
II, Influenza B virus, parainfluenza virus, cytomegalovirus, human rhinovirus type 2 
etc. 
Chemoprotective properties– Animal studies have shown that garlic has 
positive effects against hepatotoxins. The reaction of allicin in garlic with the 
sulfhydryl groups contribute to the inhibitory effect. Sulfhydryl groups concentration 
is high in rapidly dividing cells. 
Immunity– Immunity is increased due to a number of factors on consumption 
of garlic. Selenium and germanium present in garlic are said to be responsible for 
immunologic activities. Enhanced phagocytosis, increased killer cell activity, 
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lymphocyte proliferation, increased production of cytokines and reduction of immune 
suppression are the suggested mechanisms via which garlic increases immunity. 
Antioxidant properties– Allicin present in garlic is responsible for the 
increase of catalase and glutathione peroxidase enzymes which are two important 
antioxidant enzymes in the body. The other sulphur compounds may also show 
potential antioxidant properties by inhibiting lipid peroxidation in the liver and 
preventing a reaction which is considered to be one of the main features of aging in 
liver cells
[16]
. 
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3.3. PIPER BETLE  (யவற்றிகல) 
3.3.1. GUNAPADAM ASPECT 
VETRILLAI SYNONYMS 
ntw;wpiyap;d; Ngu;jidNa tpsk;gf;NfS 
Ntz;oaNjhu; jhk;Gy khjhthFk; 
rpj;jpiyahQ; rhjfyl;Rkp ahFk; 
jhk;G+yf; rz;zp ey ehfty;yp 
xj;jpiyNthk; Gyf;fd;dpahFk; 
cWgy;Yf; fofpjhd; Njfuf;rpfahk; 
ej;jiy ehfj;ij R+uzkhf;fp 
eyq;fpaNjhu; ntw;wpiyapd; ehkkhNk 
Synonyms: 
 Thamboolam  
 Thamboola valli  
 Thirayal  
 Mellilai  
 Vellilai  
 Melladagu  
Vernacular names: 
        Telugu   :  Tamalapaku 
        Kannada   :  Vilaya 
        Duk  :  Thambole 
        Bengali   :  Pan 
        Hindi   :  Paan 
        Sanskrit  :  Tambula and nagavalli  
       Gujarathi   :  Naagarvel na paan
[11] 
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Types: 
Vetrillai  :  Migundha manamum, kaaramum, nivamum illatuattu  
Kammaru vettrilai :  Karuppu niramum, karppum udayatu 
Karpoora vettrilai :  Karpoora manamum siru kaaramumudaiyatuu 
Habitat: 
 In India it’s cultivated in hot areas and saduppu nilam.  It’s a type of climber. 
It’s cultivated for its leaf. 
Parts used: 
 Leaf 
Properties: 
Taste(suvai)   :  Uraippu, Pungent (karppu) 
Quality(thanmai)  :  Veppam (hot) 
Pirivu (postdigstive effect)  :  Pungent (karppu) 
Action:  
 Stimulant, 
 Carminative  
 Astringent,  
 Aphrodisiac,  
 Antiseptic,  
 Febrifuge,  
 Stomachic, 
General properties: 
Iak; mWq;fhd; mjd; rhuq; nfhz;lf;fhw; 
igar; raj;jpak;Nghk; ige;njhbNa! – nka;naz; 
fbapd; Fzk; NghFk; fhuntw;wp iyf;Fg; 
gbAKj; njhlkpijg; ghu; 
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 Juice of betel leaf cures Iyyam, saytthiyam, kanaakkadi, muppini, urticaria. 
 Betel leaf juice cures sinusitis, head ache, stomach pain, sore throat, muppini, 
maantham and vayitruppisam. 
Therapeutic uses: 
 For sore throat and thondaiyaddaippu betel leaf is taken along with saambrani 
pathangam. 
 2-3 drops of betel leaf juice on ear for ear ache. 
 Betel leaf juice give along with ginger juice for lung disorders. 
 It is externally used for burns. 
 Heated betel leaf soaked with gingely oil applied over chest helps to relieve 
cough, difficulty to breathe. 
 Koorosani taken along with betel juice for dyspnoea, cough and cold. 
 Mercury purified by betel juice[11]. 
Other Medicinal uses: 
It is useful in bronchitis, asthma, catarrh, cough, leprosy, skin diseases, 
alcoholism, syncope, otalgia, fever, halitosis, impotency, rheumatism, dyspepsia, 
indigestion in children, pharyngitis, laryngitis, obesity, conjutivitis, night blindness, 
glandular swelling oil of betel has been used in the treatment of various respiratory 
diseases and as a local application either by gargle or by inhalation in diphtheria.  It 
has carminative properties oil shows marked irritant action on skin and mucous 
membrane. It has an antispasmodic action on involuntary muscle tissue, inhibiting 
excessive peristaltic movements of intestinal
[17]
.  
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BETLE LEAF ADDED SIDDHA FORMULATIONS (AS A ADJUVANT): 
1. ABRAHA PARPAM: 
Dosage  : 100-200mg 
Adjuvant  : Honey 
Indication  : Diabetes Mellitus and Diabetes Insipidus  
2. POORNA CHANTHROTHAYAM: 
Dosage  : 100-200mg 
Adjuvant   : Betel Leaf juice or Karpoorathi chooranam 
Indication  : Tuberculosis, Dysentery, Fever 
3. KASTHURI MATHIRI: 
Dosage  : 1-2 pills 
Adjuvant  : Betel Leaf juice or Honey 
Indication  : Heart problems, intermittent fever, fits 
4. SAANTHA SANTHROTHAYAM: 
Dosage  : 1-2 pills 
Adjuvant  : Betel Leaf juice or Honey 
Indication  : Liver diseases, constipation 
5. SAMBARANI POO MATHIRAI: 
Dosage  : 1 pill 
Adjuvant  : Betel Leaf or Pepper powder 
Indication  : Dysmenorrhea, Amenorrhea
[12] 
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3.3.2 BOTANICAL ASPECT   
PIPER BETLE 
BOTANICAL ASPECT 
Botanical name :  Piper betel 
Taxonomy classification: 
Kingdom   :  Plantae 
Division   :  Angiospermae 
Class    :  Magnoliidae 
Order    :  Piperals 
Family   :  Piperaceae 
Genus    :  Piper 
Species  :  Betel 
Botanical name : Piper betel 
Vernacular name: 
English   :  Betel Pepper 
Ayurvedha   :  Tambula, Nagavallari Nagini, Tambulavalli, Saptashiva,      
Siddha   :  Vertillai, Naga Valli, Kanmaru Vetrillai  
Unani    :  Pan, Tambool 
Telegu   :  Tamala Paku, Tamula Paku 
Marathi   :  Pan, Nagvel Vidyachepan 
Kannada   :  Veelyade Ele 
Common indian name :  Paan / Pan 
Distribution: 
 A native of java, it is cultivated in India in Assam, west Bengal, Bihar, Uttar 
Pradesh, Madya Pradesh, Maharashtra, Karnataka, tramlined and Kerala. 
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Botanical description: 
 Perennial, creeping herbs, stems semi woods climbing by short adventitious root 
leaves broadly ovate, slightly cordate, acuminate (or) acute entire, globroas, 
pentiolata, mace spikes dense, cylindrical, female spikes 2.5-5 cm long pendulous 
fruits rarely produced often sunk in the  fleshy spike, forming nodule like structure 
Parts used: 
 Whole plant and leaf[11] 
Pharmacognosy: 
 Leaves coriaccous, 10-18 by 5-12.5 cm broadly ovale acuminate, glabrous, 5-9 
nerved the suprabasai nerves usually alternate base sligntly cordate (or) 
usually rounded more (or) oblique, pentioles 1.3-2.5 cm. 
 Microscopically leaves shows a dorsiventral structure. The cutice is hot 
striated, the hypodermis contains secretorycells. The petiole shows a 
discontinuous collenchyma zone below the epidermis. Mucilage canals at the 
centre, vascular bundles graded in size arranged in arcs and multicellular 
hairs
[18]
. 
Chemical constituents(phytochemical): 
 Vitamin A &C, thiamine, riboflavin, nicotinic acid, glucose, fructose, maltose, 
sucrose malic acid, oxalic acid, amino acids viz leucine phenylalanine, 
alanine, arginine, threonine, serine aspartic acid, glutamic acid, methionine, 
valine, tyrosine, asparaginase, glycine, proline, etc
[19]
.  
Pharmacological activities: 
 Fungicidal 
 Hematicidal 
 Anti-bacterial 
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 Anti-fungal 
 Hypotensive 
 Cardiac and respiratory depressant 
 Anti- biotic 
 Mild anti infertility 
 Anthelmintic 
 Anti tuberculous 
 Anti-microbial 
 Cardiotonic 
 Stomach muscle relaxant[20] 
Action and uses: 
 When leaf is chewed, the mild anti – infective content in the leaf. Freshen 
breath and cleanse mouth.  Its constituents directly enter the blood via buccal 
mucosa as this is a direct way of entry into blood stream, it is the best way to 
deliver drugs into the blood stream during sickness. 
 The leaf contains several polyphenols that not only fights microbes, but also 
act as pain relivers and anti-inflammatory agent.  Recent studies have shown 
that the leaf contains tannins, sugar, diastase and an essential oil. 
 A particular phenol called chavical present in it has power full antiseptic 
painful are for temporary relief.  Betel leaves possess good diuretic properties.  
Therefore, it can be mixed with dilute milk and consumed by sweetening as it 
helps ease urination. 
 The oral intake of leaves decreases cough and reducing swelling of throat and 
throat irritation
[11]
. 
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3.3.3 SCEINTIFICALLY PROVEN PHARMACOLOGICAL ACTION OF 
BETEL LEAF 
Anti oxidant property: 
 The is reported das gupta and de (2004) evaluated the antioxidant activities of 
aqueous extract of the piper betel leaves by invitro methods - DPPH radicals 
scavenging activity, Superoxide scavenging activity and Hydroxyl radical 
scavenging activity. Finally, the piper betel Showed very high antioxidant 
activity. 
 Wong et al (2006) investigated the antioxidant properties of 25 edible tropical 
plants including piper betel using DPPH and FRAP assays.  Total phenolic 
content was also estimated.  Piper betel showed very high antioxidant activity. 
 Rathee et al (2006) chevibetol, allyl pyrocatechol and their respective glucosides 
were isolated from betel leaves.  Among the isolated compounds allyl 
pyrocatechol showed the best results in all the invitro experiments.  It could 
prevent Fe(II) induced lipid peroxidation (LPO) of liposomes and rat brain 
homogenates as well as gamma ray induced damage of PBR 322 plasmid DNA 
more efficient then chevibetol. 
 Maniguha et al (2009) evaluated the antioxidant of piper betel leaves.  Ethanolic 
extract of piper betel leaf showed strong antioxidant activities like reducing power 
DPPH radical, superoxide anion scavenging and deoxyribose degradation 
activities when compared with different standard such as ascorbic acid, DMSO 
and BHI
[21]
. 
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Anticancer property: 
 The leaf constituents, hydroxyl chavicol and β carotene were found to reduce the 
number of papilloma per mouse  
 Also, the constituents, β carotene and α tocopherol are reported to significantly 
inhibit DMBA induced skin tumour formation by 83-86 and 86% in swigs mice 
and 92.94 89% in male swigs bare mice respectively. 
 While hydroxyl chavicol showed 90% inhibition in swigs bare mice. 
 The constituent eugenol shows minimal protection in both the strains of mice. 
 The leaf extract of betel quid when administered simultaneously while mutagenic 
tobacco specific N nitrosamines (present in the extract of chewed tobacco) viz N- 
nitrosonornicotive (NNN) and 4 erotogenic affects and reduce the tumour 
incidence in mice. 
 The leaf extract is reported to exhibit antitumor activity in 7, 12, dimethyl benzene 
and anthracene (DMBA) treated wistar rats. 
Anti microbial: 
 The betel leaf oil posses’ strong antibacterial activity against the gram-positive 
bacteria bacillus subtills, bacillus pumillus staphylococcus aurous, salmonella 
typhi, vibrio cholera and several other pathogenic microorganisms. 
 The essential oil was also found to be more effective against tape worms (taenia 
solium) and hook worms (bunostomum trigonocephalum) than the synthetic 
anthelmintic, piperazine phosphate and hexyl resorcinol
[22]
.   
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3.4. MILAGU (மிைகு) 
3.4.1.GUNAPADAM ASPECT: 
MILAGU SYNONYMS: 
 kpsfpDlg; Ngh;jidNa tpsk;gf;NfS 
  Kjph;e;J epd;w jpiu Nghf;fp khprpahFk; 
 tsfpDl tyrKkh jPl;rzkhFk; 
  kfj;jhdJ td;khQ; rpahkkhFQ; 
 FsfpDl %zkhk; rj;Jt Ne\q; 
  Nfhyf khQ;ruJe; jdpAkhFk; 
 tsfpDl thjj;ij aWf;Ffpd;w  
  kfj;jhd kpsFf;F ehkkhNk 
      
 Thiraipokki 
 Marisi 
 Valasam 
 Thetsanam 
 Thuranam 
 Seyamam 
 Mooshnam 
 Sathuvanesam 
-Gunapadam Mooligai Vaguppu 
 nrhy;ypaNjhh; mUl;lndd;Wk; ,jw;Fg; NgU 
  nrhw;nghpa kjq;fd; vd;Wk; NgUz;lhFk; 
 my;ypa Njhh; kiyj;jpUf;f ndd;Wk; NgU 
  m\;lkhrhjp nad;Wk; ,jw;Fg; NgU 
 fy;ypaNjhh; fj;jphpr ndd;Wk; NgU 
  fUj;Jul ndd;Wk; Neh;tse;jh ndd;Wk; 
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 ky;saNjhh; nfe;jf ndd;wpjw;Fg; NgU 
  trdpj;Njhk; kpsfpdpl mjPjg; NgNu. 
- Panchakaviya Nigandu 
 
 Arutan 
 Mathengan 
 Malaithirukkan 
 Astamasathi 
 Kathirisan 
 Karvuthurudan  
 Nerrvalandan 
 Kanthakan 
Properties:  
 Taste  : Bitter, Pungent  
 Character  : Veppam 
 Class  : Pungent 
 used part : Seed 
Action s:  
 Acrid 
 Carminative 
 Stimulant 
 Antiperiodic 
 Resolvent  
 Rubefacient 
 Antivatha 
 Antidote. 
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Vernacular Names: 
 Tamil  : Milagu 
 Eng  : Pepper 
 Jehegu  : Miriyalu 
 Malayam : Kurumilagu 
 Kannadam : Menasy  
 Sanskrit : Maricha 
 Hindi  :  Kali mirich 
 Persian : Filfliaisiah 
 Bengoli : Glomorich, Morich, Kalamorich 
 Gujarathi : Kalimori 
 Urdu  : Fulfil Sioyah, Kalimirich
[11] 
 
General Characters: 
 ‘rPjRuk; ghz;L rpNy\;kq; fpuhzp%yk; 
  thjk; mUrpgpj;jk; kh%yk; XJrd;dp 
 ahrk;; mg];khuk; mld;Nkfk; fhrk; ,it  
  ehrk; fwpkpsfp dhy;” 
 
 ‘NfhZfpd;w gq;ftyp Fa;aNuh fk;thjk; 
 Nrhzpjq;f Oj;jpw;Fs; Njhd;Wk; Neha; - fhzhpa 
  fhJNeha; khjh; Fd;kq; fhkhiy ke;jk; vd;wPh; 
  VJNeha; fha; ,Uf;fpy; <q;F. 
It cures the malarial fever, anemia, diarrhoea, piles, ulcer, flatulence, anorexia, 
diabetes, cough, hemiplegia, vaginal disease, neck and nasal disorders, jaundice, 
pitham, vatham, vedhasonitha noi, and sanni. 
38 
 
Therapeutic uses 
 It is prescribed in cholerae, dyspepsia, flatulence, aliments. 
 An infusion of black pepper forms a useful stimulant gargle in relaxed sore - 
throat and hoarseness dependent there on and in toothache also. 
 Piperine is given with much benefit in gonorrhoea, haemorrhoids etc in doses of 
3 to 10 grains. 
 In Intermittent fever black pepper in doses of about a drachm is recommended to 
be given with the juice of leaves of ocimum sanctum or jeucas linifoha. 
 The drug is also used in scorpion bite[11]. 
 
MILAGU ADDED SIDDHA FORMULATIONS (AS AN ADJUVANT): 
1. Milagu thiravagam 
Dosage :  Kasu eadai 
Indication : Peptic ulcer, Indigestion, Anorexia 
2. Milagu Legium 
Dosage :  Punnai kai alavu 
Indication : Peptic ulcer, Vaivu, Diarrhoea. 
3. Karuvepilai vadagam 
Dosage :  Illanthai vithai alavu 
Indication : Anorexia, Diarrhoea, Dysentery. 
 
4. Kanthaga Chooranam 
Dosage :  Verugadi alavu 
Indication : Peptic ulcer, Indigestion, Constipation. 
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5. Sowbagiya sundi Chooranam 
Dosage :  Verugadi alavu 
Indication : Peptic ulcer, Indigestion, Diarrhoea. 
6. Pirandai Vadagam 
Dosage :  Kottaipakku alavu 
Indication : Peptic ulcer, Vomitting, Anorexia 
7. Thirikadgu Kirutham 
Dosage :  1 Spoon 
Indication : Piles, Diarrhoea. 
8. Pirandai Chooranam 
Dosage :  Verugadi alavu 
Indication : Peptic ulcer, Vomiting, piles, Abdominal, disorders. 
9. Thirikadugu thiravagam 
Dosage :  5 Drops 
Indication : Peptic ulcer, Bronchial Asthma. 
10. Muppirandai Chooranam 
Dosage :  Verugadi alavu 
Indication : Peptic ulcer, Indigestion, Piles
[12]
.  
40 
 
3.4.2. BOTANICAL ASPECTS 
MILAGU (PIPER NIGRUM) 
Taxonomical Classification: 
Kingdom  : Plantae  
  Subkingdom  : Tracheobionta  
Superdivision : Spermatophyta  
Division  : Magnoliophyta  
Class   : Magnoliopsida  
Subclass  : Magnoliidae 
Order  : Piperales 
Family  : Piperaceae  
Genus  : Piper L.  
Species  : Piper nigrum L.  
Common name:  
 Black pepper, white pepper, green pepper, peppercorn, Madagascar pepper 
(English); pippali (Sanskrit); kali mirch (Hindi, Urdu); milagu (Tamil) 
Synonym:  
 Muldera multinervis Miq. 
Habitat:  
 Montane tropical evergreen forest. 
Geography and distribution 
 Black pepper is native to the Western Ghats of Kerala State in India, where it 
grows wild in the mountains. 
 It is cultivated all over the tropics as a commercial crop. Vietnam, Indonesia, 
Brazil and India are the major producers. 
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DESCRIPTION 
Overview: 
  A climber that grows to a height or length of 10 m or more. Once the main 
stem is established it grows many side shoots to create a bushy column. 
 The plants form short roots, called adventitious roots, which connect to 
surrounding supports. 
Leaves: 
 Almond-shaped, tapering towards the tip, dark green and shiny above, paler 
green below, arranged alternately on the stems. 
Flowers:  
 Borne in clusters along flowering stalks known as spikes. 50–150 whitish to 
yellow-green flowers are produced on a spike. 
Fruits:  
 Round, berry-like, up to 6 mm in diameter, green at first but turning red as 
they ripen, each containing a single seed. 50–60 fruits are borne on each spike. 
 Fruits are picked when green and immature to produce green pepper; when 
fully grown but still green and shiny to produce black pepper; and when slightly riper 
to produce white pepper (for which the fruits are also soaked to remove the fleshy 
outer layer). 
Food 
 The fruits of Piper nigrum are used to make black pepper. This hotly pungent 
spice is one of the earliest known and most widely used spices in the world today. It is 
used as flavouring, particularly for savoury foods, meat dishes, sauces and snack 
foods. It is also used as a table condiment. 
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 Black pepper, white pepper and green peppercorns are all produced 
from Piper nigrum fruits but are harvested at different times and are processed 
differently. 
 India is a key producer of black pepper and exports much of what is grown. 
Peppercorns from Malabar and Tellicherry in Kerala, India, are particularly prized for 
their flavour and pungency
[23]
. 
Black peppercorns 
 Black peppercorns feature as remedies in Ayurveda, Siddha and Unani 
medicine in South Asia. They are most frequently used as an appetizer and to treat 
problems associated with the digestive system, particularly to eradicate parasitic 
worms. Some traditional uses of black pepper are supported by scientific evidence. 
 In Siddha medicine, black pepper has been used to aid digestion, improve 
appetite, treat coughs, colds, breathing and heart problems, colic, diabetes, anaemia 
and piles. Stomach ailments such as dyspepsia, flatulence, constipation and diarrhoea 
are all treated with black pepper, which may be mixed with other substances such as 
castor oil, cow's urine or ghee. 
 Black pepper has been prepared in tablet form as a remedy for cholera and 
syphilis, sometimes combined with other substances. It has also been used in tooth 
powder for toothache, and an infusion of black pepper has been suggested as a 
remedy for sore throat and hoarseness. Black pepper may be chewed to reduce throat 
inflammation. 
  
Pharmacological activity: 
 Constituents: Black pepper has been found to contain piperine, alkamides, 
piptigrine, wisanine, dipiperamide D, and dipiperamide E. 
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 Acetylcholinesterase inhibitory activity: In an in vitro study, an extract 
of Piper nigrum L. seeds showed 50-65% inhibitory activity on 
acetylcholinesterase. Antibacterial effects: In an in vitro study using 12 
different genera of bacterial populations isolated from the oral cavity of 200 
individuals, an aqueous decoction of black pepper (Piper nigrum L.) exhibited 
75% antibacterial activity as compared to aqueous decoction of bay leaf 
(53.4%) and aqueous decoction of aniseed (18.1%), at the concentration of 
10mL/disc 
 Anti-inflammatory effects: Based on animal study, a polyherbal formulation 
(Aller-7/NR-A2) containing extracts from seven medicinal plants 
including Phyllanthus emblica, Terminalia chebula, Terminalia 
bellerica, Albizia lebbeck, Piper nigrum, Zingiber officinale, and Piper 
longum demonstrated 31.3% inhibition against carrageenan-induced acute 
inflammation in Wistar Albino rats, while ibuprofen (50 mg/kg orally) exerted 
68.1% inhibition, Aller-7 also exhibited a dose-dependent (150-350mg/kg) 
anti-inflammatory effect against Freund's adjuvant-induced arthritis in Wistar 
Albino rats; an approximately 63% inhibitory effect was observed at a dose of 
350mg/kg. 
 Gastrointestinal effects: In a clinical study of intestinal peristalsis in 16 
healthy volunteers, consumption of 1.5g of black pepper in capsules increased 
the orofecal transit time from 90 ± 51 minutes to 122 ± 88 minutes 
(p=0.09). In an in vitro study, piperine inhibited digoxin and cyclosporine A 
transport in Caco-2 cells with IC50 values of 15.5 and 74.1mcM, 
respectively. The bactericidal and anti-adhesive properties of black pepper 
have also been investigated against Helicobacter pylori, however, aqueous 
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extracts did not show bactericidal effect on any of the isolates. Neural effects: 
In an in vitro study using whole-cell patch-clamp electrophysiology, piperine, 
a pungent alkaloid found in black pepper, had similar agonist effects on the 
human vanilloid receptor TRPV1 as capsaicin. However, piperine could 
induce greater receptor desensitization and exhibit a greater efficacy than 
capsaicin
[24]
. 
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3.5. PHARMACEUTICAL REVIEW OF MATHIRAI 
3.5.1. SIDDHA ASPECT OF THE FORMULATION OF MATHIRAI 
khj;jpiu: 
khj;jpiu ghfk;: 
fy;f jputpaq;fisj; jdpahfNtDk;> gw;gnre;J}uq;fSld; Nrh;j;NjDk; 
[yk;> f\hak;> %yifr;rhW ,itfSld; VNjDk; xd;wpy; ed;F 
cwthFk;gbmiuj;J Fwpg;gpl;l mstpd;gb khj;jpiu nra;tjhFk;. 
miug;G tpjp 
khj;jpiu nra;tjw;fhf epakpf;fg;gl;l fy;fq;fis jdpj;jdpahfr; 
#uzpj;J mstpd;gb fy;tj;jpy; ,l;L girAz;lhf;f $ba jputpankhd;wpdhy; 
eidAk;gb gprwpf; fy;tj;jpd; fPo;f;ifapy; itj;J nfhz;L nfhQ;rq; 
nfhQ;rkhff; fy;tj;jpd; Nky;ifapy; VWk;gbj; js;sp miuf;f Ntz;Lk; ,g;gb 
fPo;f;ifapy; ,Ue;j ruf;ifnay;yhk; NkNywpa gpd; kPz;Lk; gbg;gbahf 
fPo;iff;FtUk;gb js;spjs;sp miuj;jy; Ntz;Lk; ,q;qdk; Fwpj;j fhyk; 
tiuapy; miug;gpd; eph;j;Njh\khd khj;jpiuahFk;. 
khj;jpiu jpul;Lk; ghfk; 
miuf;Fk; NghJ> ruf;F fy;tj;jpy; rpwpJk; gw;whky; FotpAld; Gus 
Ntz;LtJkd;wp mJ Fotpf;Fk; fy;tj;jpw;Fk; rk;ge;jkpy;yhky; ,Uf;f 
Ntz;Lk;. 
thirid jputpaq;fs; Nrh;f;Fk; fhyk; 
f];J}hp> NfhNuhrid> mk;gh;> Fq;Fkg;G+> gr;irf; fw;G+uk;> 
Kjyhditfis khj;jpiu jpul;l 1 ehopiff;F Kd; Nrh;j;jiug;gJ ed;W. 
mq;qd Kbj;j khj;jpiufis epoYyh;j;jp clNd fy;fhh;f; rPrhtpy; 
gjdQ;nra;jy; Ntz;Lk;. 
miug;gpd; Kd; gpd; Nrh;f;f Ntz;Ltd  
gpuNahfj;jpy; miug;gjw;F vJ fbdkhdNjh mjid fy;tj;jpy; ,l;L 
miuj;J> mJ gf;Ftkhdgpd; kw;witfisg; gbg;gbahf xd;wd; gpd; 
xd;whfr;Nrh;j;J miuj;jy; Ntz;Lk;. thsk; Kjypa gUg;gpdq;fs; NrUk; 
nghOJkhj;jpiu jpul;l 1 rhkj;jpw;F Kd; Nrh;j;jy; Ntz;Lk;. Vnddpy; 
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jhsfj;ijNghd;w fbd ruf;Fld; kj;jpkkhd ruf;Frk;ge;jg;gbd; jhsfk; 
vspjpy;miuglhJ. 
thsk; Kjyait ePz;l miug;gpw;F gpd; khj;jpiu nra;J tUk;NghJ> 
mjdpypUe;J ijyk; ntspg;gLk; mjdhy; mjd; td;ik FiwAk; [25] 
 
3.5.2. MODERN ASPECT OF THE FORMULATION 
Tablet (Pill)-Kuligai 
A tablet is a pharmaceutical dosage form it otherwise called as caplet. 
Medicinal tablets are called as "pills". Originally "pills" referred specifically to a soft 
mass rolled into a ball shape, rather than a compressed powder. (wikipedia. org). 
As per Indian Pharmacopeia 2007 defined the Tablets are solid dosage forms 
each containing a unit dose of one or more medicaments. They are anticipated for oral 
route. A tablet consists an active medicament with excipients which are in powder 
form are compressed or pressed into a solid dosage form. About two third drugs 
prescribed are in solid dosage form and tablets include half of them. 
Classification: 
As per IP2007 tablets are majorly classified into following categories (Indian 
pharmacopoeia 2007) 
1. Uncoated Tablets: 
This type of tablets contains single layer or more than one layer tablet 
consisting of active ingredient with the excipients, no additional cover is applied on to 
it after the compression. 
2. Coated Tablets: 
Coated types of tablets have an additional coating layer on it after the tablet 
was compressed, the coating layer of tablets formed with sugar, gums, resins, inactive 
or insoluble fillers, plasticisers, polyhydric alcohols, waxes. 
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3. Dispersible Tablets: 
These are the film coated or uncoated tablets because a uniform dispersion 
when suspended in water 
4. Effervescent Tablets: 
These type of tablets which are uncoated and are planned to be dissolved and 
produce an dispersion before they are administered the dissolution is achieved by the 
reaction between an organic acid and bicarbonate which produce CO2, thus produced 
CO2 will disintegrate the tablet so which dissolves in the solution to produce an 
suspension which was rapidly absorbed. 
5. Modified-release Tablets: 
These types of tablets are the coated or uncoated tablets which are designed in 
such a way that the rate or location of the active ingredient released is modified. It 
includes enteric coated tablets, prolong release tablet or delay release tablet. 
A) Enteric-coated Tablets: 
These are also called as gastro resistant tablets as they resistant to the gastric 
juices; these are formulated by coating the tablet with anionic polymer of 
methylacrylic acid and their esters or by coating with cellulose acetyl pthylate. 
Ex: erythromycin, NSAIDS 
B) Prolonged- release Tablets: 
These types are otherwise called as sustain release tablets or extended release 
tablets was formulated in such a way that the active ingredient is released for a 
prolong duration of time and is available in systemic circulation after administration. 
C) Delayed-release Tablets: 
This dosage form was planned to release the drug after some time delay or 
after the tablet has passed one part of the GIT into another. All enteric coated tablets 
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are type of delayed action tablet but all delayed action of tablets was not enteric or not 
intended to produce enteric action. 
6. Soluble Tablets: 
These are coated or uncoated tablets which are planned to dissolve in water 
before they are administered. 
7. Tablets for Use in the Mouth: 
These are the tablet formulations which are planned to be show local action in 
the buccal cavity. These include buccal tablet, Sublingual Tablets and Troche or 
lozenges.Buccal tablets are placed in between the cheek and gingival. Sublingual 
tablets are placed below the tongue Eg: glyceryl trinitrate. 
8. Tablets for other routes of administration: 
These include implantable tablets and vaginal tablet. These are inserted in to 
the rectum or vagina for their local or systemic action [26]. 
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4. MATERIALS AND METHODS 
4.1.1. PREPARATION OF THE TEST DRUG: 
         4.1.2. Drug selection 
  The study drug “Rasa Karpoora Kuligai” has been selected from the classical 
siddha literature,”Gunapadam Thathu Jeeva Vaguppu”. 
 
        4.1.3. Ingredients of  Rasa Karpoora Kuligai, 
1. Purified Pooram             -            21gm 
    (Calomel/Hydrargyrum subchloride) 
2. Betel Leaves (Piper betle)             - 168gm  
3. Pepper( Piper nigrum)              - 126gm 
   
4. Garlic (Allium sativum)                             -      84gm 
5. Betel (Piper betle) leaf juice  -  Required quantity. 
 
         4.1.4. Procurement of Raw drugs: 
    All the raw materials were obtained from K.Ramasamy chetty country drug 
shop, No:177, Rasappa chetty street, Park town, Chennai-600003. Betel leaves were 
procured from Local market, West tambaram, Chennai-600045. 
         4.1.5. Identification and Authentication: 
             Pooram (Calomel) was identified and authenticated  by the Dept of 
Gunapadam  and herbal ingredients of Rasakarpoora Kuligai were  identified and 
authenticated by the Dept of  Medicinal Botany,  National Institute of Siddha, 
Chennnai - 47. 
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         4.1.6. Purification of raw drugs: 
              Pooram ( Calomel): 
      The karkam (poultice) was made from betel leaf and pepper (each 8.75gm) 
and the karkam was dissolved in 1.3 liter of water.  35gm of Calomel was tied with a 
cloth and immersed in the above medicated water and heated by  the thula iyanthiram 
process ( calomel tied with cloth immersed in the medicated water from the cross bar 
without touching the bottom of the vessels and heated). After the water is reduced to ¾ 
of its volume, the calomel is taken out, washed with water and dried under sunlight. 
Finally the purified  Calomel was stored in a air tight container. 
             Pepper: 
              Soaked pepper in the juice of Utthamani( Pergularia daemia) and dry it in 
sunlight till the juice dries up completely. 
            Garlic: 
                Peeled the skin of garlic. 
              Betel Leaves: 
                 Removed the stalk and midrib of betel leaves. 
 4.1.7. Rasa Karpoora Kuligai  preparation procedure: 
                 Purified  21 gm of Calomel, 84gm of Garlic, 126gm of  Pepper, 
and168gm of  betel leaves were taken and grinded with betel leaves juice for 15 
hours (5 samam) and then rolled into pills like sundai ( Sollanum tuberosum) 
size(0.798gms). Then it is dried in shade.  
4.1.8. Storage of test drug: 
          Rasa Karpoora Kuligai is stored in an air tight glass container. 
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4.1.9. Administration of the drug: 
Form of the drug : Kuligai 
Route   : Enteral (oral) 
Dosage  : One pill- twice a day for seven days  
Adjuvant  : Water. 
Shelf Life  : 5 years. 
4.1.10. Indications: 
Scabies, syphilis, Cervical cancer, Penile cancer, Chronic  deep ulcers and  chronic 
Pitted wounds. 
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Ingredients of Rasakarpoora kuligai 
                     
                 1.Rasakarpooram (Purified)   2.Piper betle 
 
 
 
 
 
 
 3.Allium sativum    4.Piper nigrum 
 
Prepared medicine 
     
 Rasakarpoora kuligai 
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4.2. STANDARDIZATION OF RASAKARPOORA KULIGAI: 
  
The standardization of  test drug is essential to exhibit the purity and quality  
of drug.  This is basically done by physiochemical, phytochemical, biochemical,  and 
instrumental analysis. 
 The physiochemical analysis have been done at The TN Dr.MGR Medical 
University, Guindy,Chennai-32. Biochemical analysis were done at National Institute 
of Siddha and the Instrumental analysis was done at Indian Institute of Technology 
(IIT), Chennai-36 . 
 
     4.2.1. ORGANOLEPTIC CHARECTER ANALYSIS:  
The organoleptic characters of the sample drug were evaluated.1gm of the test 
drug was taken and the colour, texture, particle size and other morphology were 
viewed by naked eye under sunlight. Then the result is noted. 
 
   4.2.2. PHYSICO CHEMICAL ANALYSIS 
 Physicochemical studies of the trial drug have been done according to the 
WHO guidelines. 
1. Determination of Ash Values: 
      1.a. Total Ash: 
2g is accurately weighed and incinerated in a crucible dish at a temperature 
not exceed 600
o
C until free from carbon. It is then cooled and weighed. The % w/w of 
ash with reference to the air-dried powder is calculated 
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1.b. Water Soluble Ash: 
The total ash is obtained as the above method for preparation of total ash. The 
ash is boiled for 5minutes with 25ml water. The insoluble ashes is collected using 
filter paper and washed with hot water and then transferred to the silica crucible then 
ignite for 15minutes at temperature not exceeding 450
o
C. The silica crucible and 
residue are weighed until constant weight is attained for determination of weight of 
insoluble ash. The weight of the water soluble ash is determined by subtracting the 
weight of insoluble ash from the weight of total ash. 
1.c. Acid insoluble Ash: 
The total ash is obtained as the above method for preparation of total ash. The 
ash is boiled for 5minutes with 25ml 10% Hcl. The insoluble ashes is collected using 
filter paper and washed with hot water and then transferred to the silica crucible then 
ignite for 15minutes at temperature not exceeding 450
o
C. The silica crucible and 
residue are weighed until constant weight is attained. 
 2. Determination of Extractive Value: 
    2.a. Alcohol Soluble Extractive Value: 
2.5gm of test drug powder is weighed and macerated with 100ml of ethanol in 
a closed container for 24 hours. The resulting solution is shaken continuously for 6 
hours and allowed to stand and soak for 18 hours. The solution is filtered and 
evaporated of the filtrate in a flat bottomed shallow dish and dried at 105
o
C then 
cooled and weighed. 
 2.b. Water soluble Extractive value: 
5gm of test drug powder is weighed and macerated with distilled water, 
respectively, at 80
o
C for 24 hrs. The resulting solution is shaken continuously for 6 
hours and allowed to stand and soak for 24 hrs then filtered. The solution from both 
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chloroform and water respectively is filtered and evaporated of the filtrate in a flat 
bottomed shallow dish and dried at 105
o
C then cooled and weighed. 
3. Loss on Drying: 
2gm of powdered drug is dried in the oven at 100- 105°C to constant weight. 
The result was noted. 
4.2.3. PHYTOCHEMICAL ANALYSIS   
       Phyto chemical Screening of the test  drug have been done using standard 
procedures 
1. Detection of alkaloids:  
       Extracts were dissolved individually in dilute Hydrochloric acid and filtered. 
 a) Mayer’s Test: Filtrates were treated with Mayer’s reagent (Potassium Mercuric 
Iodide). Formation of a yellow colored precipitate indicates the presence of alkaloids.  
b) Wagner’s Test: Filtrates were treated with Wagner’s reagent (Iodine in Potassium 
Iodide). Formation of brown/reddish precipitate indicates the presence of alkaloids.  
c) Dragendroff’s Test: Filtrates were treated with Dragendroff’s reagent (solution of 
Potassium Bismuth Iodide). Formation of red precipitate indicates the presence of 
alkaloids. 
 d) Hager’s Test: Filtrates were treated with Hager’s reagent (saturated picric acid 
solution). Presence of alkaloids confirmed by the formation of yellow colored 
precipitate.  
2. Detection of carbohydrates: 
Extracts were dissolved individually in 5 ml distilled water and filtered. The 
filtrates were used to test for the presence of carbohydrates. 
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 a) Molisch’s Test: To 2 ml of plant sample extract, two drops of alcoholic solution 
of α- naphthol are added. The mixture is shaken well and few drops of concentrated 
sulphuric acid is added slowly along the sides of test tube. A violet ring indicates the 
presence of carbohydrates.   
b) Benedict’s Test: Filtrates were treated with Benedict’s reagent and heated gently. 
Orange red precipitate indicates the presence of reducing sugars. 
3. Detection of glycosides:  
Extracts were hydrolyzed with dil. HCl, and then subjected to test for glycosides.  
a) Modified Borntrager’s Test: Extracts were treated with Ferric Chloride solution 
and immersed in boiling water for about 5 minutes. The mixture was cooled and 
extracted with equal volumes of benzene. The benzene layer was separated and 
treated with ammonia solution. Formation of rose-pink color in the ammonical layer 
indicates the presence of anthranol glycosides.  
 b) Cardiac glycoside (Keller-Killiani test):  Extract was shaken with distilled water 
(5 mL). To this, glacial acetic acid (2 mL) containing a few drops of ferric chloride 
was added, followed byH2SO4 (1 mL) along the side of the test tube. The formation 
of brown ring at the interface gives positive indication for cardiac glycoside and a 
violet ring may appear below the brown ring 
4. Detection of saponins 
a) Froth Test: Extracts were diluted with distilled water to 20ml and this was shaken 
in a graduated cylinder for 15 minutes. Formation of 1 cm layer of foam indicates the 
presence of saponins.  
b) Foam Test: 0.5 gm of extract was shaken with 2 ml of water. If foam produced 
persists for ten minutes it indicates the presence of saponins.  
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5. Detection of phytosterols  
a) Salkowski’s Test: Extracts were treated with chloroform and filtered. The filtrates 
were treated with few drops of Conc. Sulphuric acid, shaken and allowed to stand. 
Appearance of golden yellow color indicates the presence of triterpenes. 
6. Detection of phenols Ferric Chloride Test:  
Extracts were treated with 3-4 drops of ferric chloride solution. Formation of 
bluish black color indicates the presence of phenols.  
7. Detection of tannins - Gelatin Test:  
The extract is dissolved in 5 ml of distilled water and 2 ml of 1% solution of 
Gelatin containing 10% NaCl is added to it. White precipitate indicates the presence 
of phenolic compounds.  
8. Detection of flavonoids  
a) Alkaline Reagent Test: Extracts were treated with few drops of sodium hydroxide 
solution. Formation of intense yellow color, which becomes colorless on addition of 
dilute acid, indicates the presence of flavonoids. 
 b) Lead acetate Test: Extracts were treated with few drops of lead acetate solution. 
Formation of yellow color precipitate indicates the presence of flavonoids.  
9. Detection of proteins and aminoacids 
 a) Xanthoproteic Test: The extracts were treated with few drops of conc. Nitric 
acid. Formation of yellow color indicates the presence of proteins. 
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10. Detection of diterpenes Copper Acetate Test: 
 Extracts were dissolved in water and treated with 3-4 drops of copper acetate 
solution. Formation of emerald green color indicates the presence of diterpenes   
11. Gum and Mucilage:  
 To 1ml of extract add 2.5ml of absolute alcohol and stirring constantly. Then 
the precipitate was dried in air and examine for its swelling properties. Swelling was 
observed that will indicate presence of gum and mucilage. 
12. Test for Fixed oils and Fats  
a. Spot test :  
A small quantity of extract is pressed between two filter papers. Oil stain on 
the paper indicates the presence of fixed oils.  
 13. Test for Quinones 
Extract was treated with sodium hydroxide blue or red precipitate indicates the 
presence of Quinones. 
4.2.4. BIO CHEMICAL ANALYSIS: 
  1. Preliminary Basic and Acidic radical: 
Preparation of the extract: 
5gms of the test drug is weighed accurately and placed in a 250ml clean 
beaker.  Then 50ml of distilled water is added and dissolved well.  Then it is boiled 
well for about 10 minutes.  It is cooled and filtered in a 100ml volumetric flask and 
then it is made up to 100ml with distilled water. This preparation is used for the 
qualitative analysis of acidic/ basic radicals and biochemical constituents in it.  
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1.a.  Qualitative analysis for basic radicals: 
    1.a.1. Test for Calcium: 
 2ml of the above prepared extract is taken in a clean test tube. To this add 2ml 
of 4% Ammonium oxalate solution. Formation of white precipitate indicates the 
presence of calcium. 
1.a.2. Test for Iron (Ferric): 
 The extract is acidified with glacial acetic acid and potassium ferro cyanide. 
Formation of blue colour indicates the presence of ferric iron. 
1.a.3. Test for Iron (Ferrous): 
 The extract is treated with concentrated Nitric acid and ammonium thio-
cyanate solution. Formation of blood red colour indicates the presence of ferrous iron. 
1.a.4. Test for Zinc: 
 The extract is treated with potassium ferro-cyanide. Formation of white 
precipitate indicates the presence of zinc. 
1.b. Qualitative analysis for acidic radicals: 
    1.b.1. Test for Sulphate: 
 2ml of extract is added to 5% barium chloride solution. Formation of white 
precipitate indicates the presence of sulphate. 
1.b.2. Test for Chloride: 
 The extract is treated with silver nitrate solution. Formation of white 
precipitate indicates the presence of chloride. 
1.b.3. Test for Phosphate: 
 The extract is treated with ammonium molybdate and concentrated nitric acid. 
Formation of yellow precipitate indicates the presence of phosphate. 
 
60 
 
1.b.4. Test for Carbonate: 
 On treating the extract with concentrated hydrochloric acid giving brisk 
effervescence indicates the presence of carbonate. 
1.b.5. Test for starch: 
 The extract is added with weak iodine solution. Formation of blue colour 
indicates the presence of starch. 
1.b.6. Test for albumin: 
 The extract is treated with Esbach`s reagent. Formation of yellow precipitate 
indicates the presence of albumin. 
 1.b.7. Test for tannic acid: 
 The extract is treated with ferric chloride. Formation of bluish black 
precipitate indicates the presence of tannic acid. 
1.b.8. Test for unsaturation: 
 The extract is treated with potassium permanganate solution. The dis-
colourization of potassium permanganate indicates the presence of unsaturated 
compounds. 
1.b.Test for the reducing sugar: 
 5ml of Benedict`s qualitative solution is taken in a test tube and allowed to 
boil for 2 minutes and added 8-10 drops of the extract and again boil it for 2 minutes. 
Any colour change indicates the presence of reducing sugar. 
Test for amino acid: 
 One or two drops of the extract is placed on a filter paper and dried it well. 
After drying, 1% Ninhydrin is sprayed over the same and dried it well. Formation of 
violet colour indicates the presence of amino acid. 
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4.2.5. INSTRUMENTAL ANALYSIS: 
4.2.5.1. SEM (SCANNING ELECTRON MICROSCOPE):  
    External morphology, texture, crystalline structure, chemical composition and  the 
shape of the test drug – Rasa Karpoora Kuligai  was analysed through SEM as per 
standard procedure. 
 
                                             SEM INSTRUMENT 
 
                   
                SEM - SCANNING ELECTRON MICROSCOPE 
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MECHANISM 
In scanning electron microscope high-energy electron beam is focused through 
a probe towards the sample material. Variety of signals was produced on interaction 
with the surface of the sample. This results in the emission of electrons or photons and 
it is collected by a appropriate detector.  
The types of signal produced by a scanning electron microscope include  
 Secondary electrons 
 back scattered electrons 
 characteristic x-rays, light 
 specimen current 
 Transmitted electrons. 
 This gives the information about the sample and it includes external morphology, 
texture, its crystalline structure, chemical composition and it displays the shape of the 
sample 
4.2.5.2. ICP-OES (INDUCTIVELY COUPLED PLASMA OPTIC 
EMISSION SPECTROMETRY): 
                Presence of  Havy mentals and other elements in the Rasa Karpoora Kuligai was 
analysed by ICP-OES as per standard procedure. 
 
                                   ICP-OES 
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Manufacturer :     Perkin Elmer 
Model     :       Optima 5300 DV ICP-OES Inductively Coupled Plasma      
Spectrometer (ICP) 
Principle : 
An aqueous sample is converted to aerosols via a nebulizer. The aerosols are 
transported to the inductively coupled plasma which is a high temperature zone 
(8,000– 10,000ºC). The analysts are heated (excited)to different (atomic and/or ionic) 
states and produce characteristic optical emissions (lights). These releases are 
separated based on their respective wavelengths and their strengths are measured 
(spectrometry). The intensities are proportional to the concentrations of analyses in 
the aqueous sample. The quantification is an external multipoint linear standardization 
by comparing the emission intensity of an unknown sample with that of a standard 
sample. Multi-element calibration standard solutions are prepared from single- and 
multi element primary standard solutions. With respect to other kinds of analysis 
where chemical speciation is relevant (such as the concentration of ferrous iron or 
ferric iron), only total essential concentration is analysed by ICP-OES. 
Application: 
        The analysis of major and minor elements in solution samples. 
Mechanism:  
In plasma emission spectroscopy (OES), a sample solution is presented into 
the core of inductively coupled argon plasma (ICP), which generates temperature of 
approximately 8000°C. At this temperature all elements become thermally excited 
and emit light at their characteristic wavelengths. This light is collected by the 
spectrometer and passes through a diffraction grating that serves to resolve the light 
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into a spectrum of its essential wavelengths. Within the spectrometer, this deflected 
light is then collected by wavelength and amplified to yield an strength of  
measurement that can be converted to an elemental concentration by comparison with 
standardizationvalues 
The Inductively Coupled Plasma Optical Emission Spectrometric (ICP-OES) 
analysis was done in Saif, IIT Madras, and Chennai-36 using Perkin Elmer Optima 
5300 DV. 
Sample preparation: 
Inductively Coupled Plasma Spectroscopy techniques are the so-called "wet" 
sampling methods whereby samples are introduced in liquid form for analysis. 
100 mg “Rasa karpoora kuligai” was occupied in a clean, dry test tube. To 
this, 3 ml Nitric acid was added and mixed well and allowedfor few minutes untill the 
reactions were completed. And then, 25 ml of Refined water, was added to prepare 
digested solution.  
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4.3. TOXICOLOGICAL STUDIES 
PRECLINICAL TOXICITY STUDIES OF RASA KARPOORA KULIGAI (RKK) 
ON WISTAR ALBINO RATS 
4.3.1.  Acute toxicity study 
4.3.2.  28 days Repeated oral toxicity study. 
        The toxicity studies were carried out after getting IAEC approval from 
National Institute of Siddha, Chennai-47. (IAEC approval No: 
NIS/IAEC/13/2016, dated 29.9.2016) 
4.3.1. ACUTE TOXICITY STUDY IN FEMALE WISTAR RATS: 
 Aim: 
The aim of this Study is to evaluate the toxicity/ safety  of the test substance 
Rasa Karpoora Kuligai, when administered orally to Female Wistar Rats with 
different  single doses as per OECD guide line 423.  
Experimental details: 
1.Animal 
 The female wistar  albino rats of weighing 150-200gm were obtained from 
authorized animal breeders of the animal laboratory in TANUVAS, Madhavaram, 
Chennai and stocked in the animal house at National Institute of Siddha, Chennai.the 
animal are acclimatized for seven days prior to do toxicity study. 
  2.Diet and water 
All the rats had free access to a pellet rat diet. The diet was analyzed by the   
manufacturer to check its composition and to detect possible contaminants. The RO 
water was offered ad libitum in bottles.  
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3.  Animal selection and Identification 
The animals are randomly selected for each group. Each group contain three  
female animals.   They were marked on head, body and tail with picric acid solution 
prepared in water for identification in each group. The group no., cage no., sex of the 
animal and animal no. were  indicated below the cage in label. 
 
     Numbering and Identification of  test animals 
                   
 
 
 
 
 
  4.  Dose of Test substance & Dose Preparation:    
             The doses  of the test substance for the study were selected based on OECD 
guidline-423 and IAEC committee recommendation. 
 
Dose of test substance for each group 
GROUP DOSE 
GROUP DOSE 
Group-I Control 
Group-II 300 mg/kg 
Group-III 2000 mg/kg 
 
Group No         Animal Marking 
I Head, Body and Tail (H,B,T) 
II    Head, Body and Tail (H,B,T) 
Lll Head, Body and Tail(H,B,T) 
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                  Rasakarpoora kuligai was finely powdered and mixed with twine 80 to make 
as completely dissolved form for oral administration. The dose was prepared of a 
required concentration before dosing by dissolving in distilled water. The preparation 
for different doses was vary in concentrations to allow a constant dosage volume. 
The test drug was administered as single dose. After single dose 
administration period, all animals were observed for further 14 days. 
5.Route of administration 
                  Oral route was selected because it is the normal route of clinical 
administration. 
           6. Administration of Dose 
            The animals were fasted (only food was withheld) for 12hrs and weighed 
prior to dosing. Three animals were used for each group. A single dose of the test 
drug  solution (300,2000mg/kg) was consecutively administered by oral gavage using 
intubation cannula. The food was withheld for another 4hrs after dosing. The 
toxicological effect was assessed on the basis of mortality.  
7. Experimental procedure:  
           Female wistar Albino Rats of weighing 150-200g were used for acute toxicity     
study. Animals were housed in a cage at 22°C ±3°C and relative humidity 30–70% and 
have free access to standard rat pellet diet.  After seven days of acclimatization the 
animals are divided into three groups randomly (Group I, II &III). Each group contains 3 
female wistar albino rats. Group I served as a control and treated with water.The 
remaining two groups were treated with 300mg/kg.b.wt and 2000mg/kg.bwt  dosage of  
Rasa Karpoora Kuligai by oral route after 12 hrs fasting  with free from water. After drug 
administration behavioural parameters are monitored for the first 4 hours continuously 
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(1/2 hr, 1hr, 2 hr, 3 hr,4 hr) and recorded. Then the animals are observed once daily  for 
further 14 days for any mortality and morbidity. The animals are die within this period 
will be subjected to necropsy. Remaining animals will be weighed and sacrificed under the 
intra peritoneal injection of Pentothal Sodium on the 15
th
 day of the Study period. The 
toxicological effect was assessed on the basis of mortality. 
8.Observations: 
      Observations were made and recorded systematically and 
continuously observed after the substance administration as per the 
guidelines. 
       ½ hour, 1 hour, 2 hours, 4 hours and up to 24 hours observation 
All rats were observed twice daily for 14 days
 
Body weight  were Calculated weekly once
 
       Feed & water intake were Calculated daily
 
Cage side observation 
The animals were monitored for behavioral parameters like Alertness, 
Aggressiveness, pilo erection, Grooming, Gripping, Touch Response, Motor 
Activity, Tremors, Convulsions, Muscle Spasm, Catatonia, Muscle relaxant, 
Hypnosis Analgesia, Lacrimation, Exophthalmos, Diarrhea, Writhing, 
Respiration, Mortality. 
Gross necropsy: 
At the end of the 14 
th
 day, all the animals were sacrificed by using the 
intra peritoneal  injection of Pentothal sodium. Gross necropsy includes 
examinations of the external surface of the body, all orifices, cranial, thoracic 
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and abdominal cavities and their contents. Brain, eye, lungs, heart, spleen, 
liver, kidneys, adrenals and uterus of all animals. 
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4.3.2:  28 DAYS REPEATED ORAL TOXICITY STUDY IN WISTAR ALBINO 
RATS TO EVALUATE TOXICITY PROFILE OF   
RASA KARPOORA KULIGAI 
1. Aim 
The aim of this study was to assess the toxicological profile of the test item 
when treated as a single dose for 28 days. This study provides information on the 
possible health hazards likely to arise from exposure over a relatively limited period 
of time.  
2. Test Guideline Followed 
          OECD guideline 407 Method - Sub-Acute Toxic Class Method (Repeated 
Dose 28-Day Oral Toxicity Study in Rodents). 
3. Study drug: 
  Rasa Karpoora Kuligai. 
4. Experimental details: 
Species:                          Wistar Albino Rats 
Sex:                                 Male and Female. 
Age/Weight :                  6 weeks/150-200 gm b.wt. 
Acclimatization period: 7 days prior to dosing 
Housing:                            Poly propylene cages bedding with Husk. 
Husbandary:                12hrs light and 12 hrs dark, 22°C ± 3°C   & 
Relative humidity 30–70%. 
 Feed:                                Rodent pellet feed 
Water:                              RO water adlibitium. 
                         Identification:                Animals are kept in poly propylene cages and 
marked- Head,body,tail,head body & Bodytail. 
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                           Groups: Randomization 
                          No. Of Animals for each group: 5 Male and 5 Female. 
5. Experimental procedure:  
             150-200 gms of 20 male and 20 female wistar albino rats are used for 
28 days repeated oral toxicity study. The animals are divided into four groups. 
Each group constains 10 animals ( 5 Female and 5 Male). The first group 
treated as control and second, third, fourth groups were treated with Low dose 
230mg/kg/ b.wt, Mid dose 450mg/kg/b.wt, High dose 600mg/ kg/ b.wt of 
Rasakarpoorakuligai mixed with twin80 and RO water for 28 days 
respectively after 12 hrs of fasting with   free from water. The low dose, mid 
dose and high dose of test drug will be calculated from human therapeutic 
dose based on by using the conversion table Paget and Barnes 1964. The 
control animals were administered with twin 80 mixed  RO water.  
           The administration was given by oral, once daily for 28 consecutive days. 
The animals were observed the behavioural parameters for the study period. Body 
weight of the animal was being monitored at weekly intervals. Food & water 
intake were Calculated daily. All the animals were sacrificed at the end of the 
study (29 days) by using the intra peritoneal injection of Pentothal Sodium as 
prescribed dose level. Blood was collected from the anesthetized animals from the 
Abdominal aorta for the following investigations like Haematology and 
Biochemical analysis. Gross pathological changes were monitored in all the 
organs then the  vital organs were  preserved and subjected to  Histopathological 
examination. 
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Observations: 
Experimental animals were kept under observation throughout the course 
of study for the following 
 All rats were observed twice daily for 28 days 
 Body weight were Calculated weekly once 
 Feed & water intake were Calculated daily 
 
a.Cage side observation 
The animals were monitored for behavioral parameters like, Alertness, 
Aggressiveness, piloerection, Grooming, Gripping, Touch Response, Motor 
Activity, Tremors, Convulsions, Muscle Spasm, Catatonia, Muscle relaxant, 
Hypnosis Analgesia, Lacrimation, Exophthalmos, Diarrhea, Writhing, 
Respiration, Mortality. 
Laboratory Investigations: 
On the 29
th
 day, the animals were fasted overnight, then anesthetized to 
collect blood samples from the abdominal aorta in two tubes: one with EDTA 
for hematological parameters, another one without anticoagulant and was 
centrifuged at 4000 rpm at 4°C for 10 minutes to obtain the serum for 
biochemical parameters. 
Hematological Investigations: 
Blood samples of control and drug treated  rats were analyzed for 
haemoglobin (Hb), total red blood corpuscles (RBC), white blood corpuscles 
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(WBC) count, Platelet, Mean corpuscular volume (MCV), Mean corpuscular 
hemoglobin (MCH), were calculated by auto analyzer. 
Biochemical Investigations: 
Serum samples of control and experimental animals were analyzed for, Bilirubin, 
BUN, Creatinine, Triglyceride, Total Cholesterol, HDL, LDL, VLDL, using 
standard methods. Activities of glutamate oxaloacetate transaminase/Aspartate 
aminotransferase (GOT/AST), glutamate pyruvate transaminase/ Alanine 
aminotransferase (GPT/ALT) were estimated as per the colorimetric procedure. 
 Necropsy: 
             All the animals were sacrificed on the 29
th
 day and  Gross necropsy 
includes examinations of the external surface of the body, all orifices, cranial, 
thoracic and abdominal cavities and their contents. Brain, eye, lungs, heart, 
spleen, liver, kidneys, adrenals and  sex organs of all animals were recorded. 
Histopathology: 
The organs included liver, kidneys, spleen, brain, heart, lungs, 
stomach, testis and uterus  of the animals were preserved, and they were 
subjected to Histopathological examination. 
Histopathological investigation of the vital organs was done. The 
organ pieces (3-5µm thick) of all the animals (low, mid, high) w e r e 
preserved and fixed in 10% formalin for 24 hrs. Samples were dehydrated in 
an auto technic and then cleared in benzene to remove absolute alcohol. 
Embedding was done by passing the cleared samples through three cups 
containing molten paraffin at 50
o
C and then in a cubical block of paraffin 
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made by the “L” molds. It was followed by microtome and the slides were 
Prepared then stained with Haematoxylin-eosin. 
Statistical analysis: 
Findings such as body weight changes, food consumption, water 
intake, and hematology and biochemical analysis were subjected to One-way 
ANOVA Dunnet’s test using a computer software program followed by D 
Graph Pad Instat-3. 
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5. RESULTS AND DISCUSSION 
Many studies have been carried out to bring the efficacy and potency of the 
drug Rasa karpoora kuligai. The present study includes literary collections, 
organoleptic character, physicochemical and instrumental analysis, and toxicological 
analysis of Rasakarpoora kuligai. The drug Rasa karpoora kuligai has been usefull 
for treating diseases such as cervical cancer(yoni putru), penis cancer (linga putru), 
chronic ulcers and skin diseases in reference with the text “Gunapadam Thathu 
Jeevam”. 
 
 5.1. LITRATURE REVIEW: 
 Literature collections about the drug from various text books were done. Siddha 
literatures related to the drug bring the evidence and importance of its utility in 
treating the cancer.  
 Botanical aspect explains the identification, description, active principle and 
medicinal uses of the plants ingredients of Rasa Karpoora Kuligai.  
 Modern and Siddha aspect of the drug was also reviewed. 
 
5.2. STANDARDIZATION OF THE TEST DRUG: 
Standardisation of the drug is more essential to derive the efficacy and potency 
of the drug, which was analysed by the various methods.  The results of  organoleptic 
charecters, physicochemical,phyto chemical analysis and Instrumental analysis have 
been done and tabulated.  
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5.2.1.  Organoleptic characters: 
The following characters have been noted in Rasa karpoora kuligai. 
                                                    Table  no:1 
Colour in day light  Brown 
Smell Pleasant odour  
Taste Bitter, L.Pungent 
Appearance Round 
Touch Hard 
 
5.2.2. Table No:2. Physicochemical properties: 
 
Parameter 
 
Result 
Loss on drying  5.71 % 
Total Ash content 6.87% 
Acid insoluble ash Less than 1% 
Water soluble ash 2.54% 
Water sol.Extraction 32.35% 
Alcohol sol.Extraction 18.63% 
 
The table no: 2 shows results of Physico chemical properties of RasaKarpoora 
Kuligai. These suggest: 
       Total Ash: Total ash value of plant material indicated the amount of minerals and 
earthy materials present in the plant material. The total inorganic content (ammonium, 
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potassium, calcium, chloride, iron, etc.,) present in the drug is measured through the 
Total ash value and it is of 6.84 % for RKK. 
       Acid insoluble ash: The acid insoluble ash value of the drug denotes the 
amount of siliceous matter present in the plant. The quality of the drug is better if the 
acid insoluble value is low. In Rasa Karpoora Kuligai acid insoluble ash is less than 
1% . It denotes the quality of RKK. 
        Water soluble ash: Water-soluble ash is the part of the total ash content, 
which is soluble in water. It is 2.54 % in RKK. 
        Water soluble extraction: Water soluble extractive value is 32.35 % in RKK. 
        Alcohol soluble ash: Alcohol-soluble extractive value is 18.63%  in RKK. 
          The percentage of soluble matters present in the drug is determined by the 
values of water extractive and ethanol extractive. Based on the extractive value 
suitable solvent can be selected. It also gives the percentage of drug which will 
correlate with the metabolism reactions. Water-soluble extractive value plays an 
important role in evaluation of crude drugs. The alcohol-soluble extractive value was 
also indicative for the same purpose as the water-soluble extractive value. 
Loss on drying: 
          The total of volatile content and moisture present in the drug was established in 
loss on drying. Moisture content of the drug reveals the stability and its shelf-life. 
High moisture content can adversely affect the active ingredient of the drug. Thus low 
moisture content could get maximum stability and better shelf life. Loss on drying of 
Rasa Karpoora Kuligai is 5.71%. This result suggest stability better shelf life  of 
RKK.   
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5.2.3. Phytochemical analysis: 
The Preliminary phytochemical studies of aqueous extract of Rasa Karpoora 
Kuligai were done using standard procedures. The results were presented in tables.  
Table No. 3:  Result of Phytochemical screening - Qualitative 
S.no Phytochemicals Test Name H2O ext. 
1.  Alkaloids 
  
  
Mayer’s Test -ve 
Wagner’s Test -ve 
Dragendroff’s Test -ve 
Hager’s Test -ve 
2.  Carbohydrates 
  
Molisch’s Test: +ve 
Benedict’s Test +ve 
3.  Glycoside 
  
Modified Borntrager’s Test -ve 
Cardiac Glycoside- Keller-Killiani test) -ve 
4.  Saponin  
   
Froth Test -ve 
Foam Test -ve 
5.  Phytosterol Salkowski’s Test -ve 
6.  Phenols Ferric Chloride Test -ve 
7.  Tannins Gelatin Test -ve 
8.  flavonoids  Alkaline Reagent Test -ve 
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Lead acetate Test +ve 
9.  Proteins and amino 
acids 
Xanthoproteic Test -ve 
10.  Diterpenes Copper Acetate Test +ve 
11.  Gum and Mucilage Extract + alcohol -ve 
12.  Fixed oils and Fats Spot test -ve 
13.  Quinones NAOH + Extract -ve 
                                   
                    Note:   +ve/-ve denotes present / absent if component tested. 
         Phyto chemical analysis shows ( Table No: 3) Carbohydrates, Flavinoids and 
Diterpenes  present in  RasaKarpoora Kuligai.  
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5.2.4. Bio Chemical Analysis: 
              Table  No. 4: Result of basic and acidic radical’s studies: 
 
 
 
 
 
 
 
 
From the basic and acidic radical studies Calcium, Sulphate, Chloride, Starch, 
Ferrous iron, Phosphate, Unsaturated compounds are present in Rasa Karpoora 
Kuligai.           
Calcium is a major component of bones and teeth. It also is required for the 
clotting of blood to stop bleeding and for normal functioning of the nerves, muscles, 
and heart. Individuals who had a calcium intake of more than 700 mg per day had a 
35 percent to 45 percent reduced risk of cancer of the distal (lower) part of the colon. 
Parameter Result 
Test for Calcium Present 
Test for Sulphate Present 
Test for Chloride Present 
Test for carbonate Absent 
Test for Starch Present 
Test for Iron [Ferric] Absent 
Test for Iron [Ferrous]  Present 
Test for Phosphate Present 
Test for Albumin Absent 
Test for  Tannic acid Absent 
Test for  Unsaturation Present 
Test for the Reducing sugar Absent 
Test for Amino acid Absent 
Test for Zinc Absent 
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In a study that included more than 61,000 Swedish women, colorectal cancer risk was 
approximately 28 percent lower among individuals who had the highest calcium 
intakes (approximately 800–1000 mg per day).  High intakes of total calcium, dietary 
calcium, and supplemental calcium were associated with an approximately 20 percent 
lower risk of colorectal cancer.  
Chloride regulates the acid base balance of the body fluids, by maintaining the 
osmotic pressure of the body fluids. In severe diarrhoea vomiting, large amount of 
water and electrolytes are lost from body. The dehydration has to be treated by 
administering water and these electrolytes.  
Ferrous Iron is easily soluble and readily absorbed from intestine. It is the 
liquid form of iron. Iron helps to proper function of the human body. 
          Starches functions much like dietary fibre. They provide nutrition for the 
beneficial bacteria in the colon, keeping them thriving and health.  Dietary fibre in 
starch reduces effects of haemorrhoids, diverticulosis & controls blood pressure.  
          Reducing sugars can react with other parts of the food like amino acids to 
change colour and taste of the food. Reducing sugars like Glucose is essential for 
brain function and physical energy. Carcinoma of prostate (Ca P), the most common 
malignancy in men, is also the second most common cause of cancer deaths in men.  
        Phosphate reduce the risk for the development of prostatic diseases, both 
benign prostatic hyperplasia and Ca.  
          Calcium, Sulphate, Chloride, Starch, Ferrous iron, Phosphate, Unsaturated 
compounds are present in Rasa Karpoora Kuligai suggest this drug have anticancer 
potency.          
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5.2.5. INSTRUMENTAL ANALYSIS 
   a. ICP-OES (Inductively Coupled Plasma Optical Emission Spectroscopy): 
The drug (Rasa karpoora kuligai) sample was analysed by the Inductively 
Coupled Plasma Optical Emission Spectroscopy (ICP-OES) to detect the trace 
elements and other elements quantitatively. The result of ICP-OES is given on the 
Table. 
Table  No.5 : ICP-OES of Rasa Karpoora Kuligai 
S. no Elements Wavelength (nm) Concentration 
1. Al 396.152 BDL 
2. As 188.979 BDL 
3. Ca 315.807 11.160 mg/L 
4. Cd 228.802 BDL 
5. Cu 327.393 BDL 
6. Fe 238.204 BDL 
7. Hg 253.652 BDL 
8. K 766.491 13.801 mg/L 
9. Mg 285.213 BDL 
10. Na 589.592 14.310 mg/L 
11. Ni 231.604 BDL 
12. Pb 220.353 BDL 
13. P 213.617 86.321 mg/L 
14. S 180.731 BDL 
15 Zn 206.200 01.058 mg/L 
BDL:Below Detectable Limit 
1% = 10000ppm, 1ppm = 1/1000000 or 1ppm = 0.0001% 
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     ICP-OES results suggest heavy metals like Arsenic,Mercury,Cadmium and 
Lead are below dedectable limits in RasaKarpoora Kuligai. So the RKK have  safe for 
consumption. Calcium (11.160mg/L), Pottasium(13.801mg/L), Sodium(14.310mg/L), 
Phosporus (86.321 mg/L) and Zinc(01.058mg/L) present in RKK.   
High intakes of total calcium, dietary calcium, and supplemental calcium were 
associated with an approximately 20 percent lower risk of colorectal cancer  
Potassium is one of the major electrolytes that the body carefully controls for 
proper heart and neuromuscular activity.  
Sodium is one of the major electrolytes, carefully maintained within a narrow 
normal range and necessary for proper functioning of the body’s systems. Low 
sodium levels, or hyponatremia, occur in a wide variety of medical disorders 
including cancer. Low sodium levels can occur in patients whose cancers produce 
ADH-like hormones, from other cancer complications and different treatment side 
effects. Cancers such as small cell lung carcinoma, pancreatic cancer, lymphoma and 
certain brain tumors can cause due to low sodium level. 
Phosphate reduce the risk for the development of prostatic diseases, both 
benign prostatic hyperplasia and Ca. 
Zinc is essential for growth. It has been used in traditional medicine for 
everything from healing wounds to preventing blood clots. It can also help increase 
the blood flow. It has anti-oxidant properties that protect the cells from damage. It can 
produce healthy veins and arteries that enhance the blood circulation.  
The presence Calcium, Sodium, Phosphate and Zinc in Rasa Karpoora Kuligai 
have the strong evidence for its anti oxidant, wound healing and anticancer potency.  
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                            Scanning Electron Microscope (SEM) analysis: 
FIG-1: SEM analysis of Rasa Karpoora Kuligai 
 
 
 
 
 
 
 
 
                              SEM PICTURE at 24,000 MAGNIFICATION. 
 
Figure-2: SEM analysis of Rasa Karpoora Kuligai 
 
 
 
 
 
 
 
 
 
       SEM PICTURE at  40,000 MAGNIFICATION. 
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             Scanning Electron Microscopy (SEM) is the best method to determine the size 
distribution of nanoparticles present in the sample. It has been used for this purpose of 
computer-assisted counting of nanoparticle images. SEM analysis of the 
Rasakarpoorakuligai shows that the uniform distribution of particles presents in the 
entire field. Most of the particles present in the sample is nano size and near nano 
size, average particle size is 4.64µm - 7.51µm. 
Siddhars were the great scientist in ancient times. They used nano technology 
for the preparation of Medicines. These Nano particles have beneficial properties that 
can be used to improve drug delivery system. Target cells take up these nano particles 
quickly because of their smaller size, lesser particles enhance the bio absorption and 
bio availability resulting better efficacy of the drug. Larger particles could not enter in 
to the target cell because of their size, resulting they cleared from the body. If a drug 
is cleared too quickly from the body, this could force a patient to use high dose, which 
leads to contraindication of the drugs. The Lesser particles from drug delivery system 
lower the volume of distribution and reduce the effect on non target tissue.  
        Nano range  and uniform distrbution of RKK suggest it has better bioavailability 
and absorption. 
5.2.6. EVALUATION OF ACUTE TOXICITY OF RASA KARPOORA KULIGAI 
           5.2.6.1. Effect of Acute Toxicity of RasaKarpoora Kuligai 
Table No.6:  Physical and behavioral examinations. 
 
Group no. Dose(mg/kg) Observation 
sign 
No. of animal affected. 
Group-I Twin 80 with 
Ro Water. 
Normal 0 of 3 
Group-II 300mg/kg Normal 0 of 3 
Group-III 2000mg/kg Normal 0 of 3 
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                Table No.7:  Behavioural Signs of Acute Toxicity Study 
 
 
Note: A- Absent of activity, N- Normal & P- Present of activity. 
 
 
          All the data were summarized in the form of  table revealed that there was no 
abnormal signs and behavioural changes in all animals at the dose level of  300, 2000 
S.N 
 
Response in 
300mg/kg.bw 
& 2000 mg /kg 
b.wt dosage of 
RKK 
Head Body Tail 
Before After Before After Before After 
1 Alertness N - N - N - 
2 Grooming A - A - A - 
3 Touch response P - P - P - 
4 Torch response P - P - P - 
5 Pain response A - A - A - 
6 Tremors A Present A Present A Present 
7 Convulsion A Present A Present A Present 
8 Righting reflux A Present A Present A Present 
9 Gripping 
strength 
P - P - P - 
10 Pinna reflux P - P - P - 
11 Corneal reflux P - P - P - 
12 Writhing A - A - A - 
13 Pupils N - N - N - 
14 Urination N - N - N - 
15 Salivation A - A - A - 
16 Skin colour N - N - N - 
17 Lacrimation A - A - A - 
18 Hyper activity A Present A present A Present 
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mg/kg body weight administered orally, during the study period. There was no 
mortality observed after dosing of Rasa Karpoora Kuligai upto 2000mg/kg body 
weight This indicates that LD50 of Rasa Karpoora Kuligai is more than 2000mg/kg 
b.wt. 
         There were no changes in skin and fur, eyes and mucous membranes of all 
animals. The eating, drinking habit, sleep pattern, locomotion were normal in all 
animals and no changes in body weight as compared to control group. At the end of 
the 14
th 
day, necropsy was performed and there was no abnormality seen in test groups 
as compared to control group during the examination. 
5.2.6.8. 28 DAYS REPEATED ORAL TOXICITY STUDY OF 
RASA KARPOORA KULIGAI  
Table No.8: Body weight changes of test animals in 28 days repeated oral toxicity 
study of Rasa Karpoora Kuligai 
GROUP CONTROL RKK. LOW 
DOSE 
230mg/kg 
RKK.MID DOSE 
 450mg/kg 
 RKK.HIGH                      
DOSE600mg/kg
  
0,DAY 126.667±1.42984 117.5±0.718795 98.3333±0.954521 95.8333±1.7966 
7
th 
DAY 132.667±1.42984 123.5±0.921955 104±1.06458 101.667±1.72562 
14
th 
DAY 138.5±1.40831 131±1.41421 110.167±1.27584 107.333±1.7062 
21
st  
DAY 144.5±1.40831 137±1.52753 116±1.18322 113±1.59165 
28
th
  DAY 150.333±1.52023 143.5±1.82117 121.667±1.22927 118.667±1.68655 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by 
one way ANOVA followed by dunnett’s(N=10); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group. 
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 Table No.9: Organ weight changes in grams of test animals in 28 days repeated 
oral toxicity study of Rasa Karpoora Kuligai 
  
GROUP CONTROL 
RKK. LOW 
DOSE 
230mg/kg 
RKK.MID 
DOSE 
450mg/kg 
RKK. HIGH 
DOSE 
600mg/kg 
BRAIN 1.256±0.2052 1.232±0.1547 1.499±0.2023 1.159±0.2025 
HEART 0.8727±0.04385 0.8323±0.06207 0.738±0.03329 0.6877±0.02028 
LIVER 6.019±0.359 8.448±0.652 6.706±0.07517 5.779±0.338 
LUNGS 1.447±0.1242 0.9353±0.03152 1.671±0.1854 1.278±0.2453 
 
KIDNEY 
L 0.7613±0.03038 0.8533±0.06263 0.8533±0.05191 0.7467±0.02533 
R 0.7453±0.03374 0.8287±0.06534 0.721±0.01721 0.7333±0.02809 
TESTIS 3.095±0.1521 2.517±0.1654 3.295±0.08581 3.11±0.1176 
UTERUS 0.736±0.02501 0.9607±0.05447 0.985±0.03436 1.214±0.306 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated 
by one way ANOVA followed by dunnett’s(N=10); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group.  
 
Table  No: 10  Effect of 28 days repeated dose of Rasa Karpoora Kuligai on 
Haematological parameters 
GROUP CONTROL RKK. LOW 
DOSE 
230mg/kg 
RKK.MID 
DOSE 
450mg/kg 
RKK. HIGH 
DOSE 
600mg/kg 
RBC (X10^6/µL) 
4.573±0.1139 5.39±0.3035 4.853±0.6894 5.8±0.3617 
 
WBC(X10^3/µL) 
 
12.5±1.531 
 
11.47±0.5783 
 
13±1.007 
 
11.43±0.3756 
 
 
HB (g/dl) 
 
10.5±0.5859 
 
13.2±0.8963 
 
11.83±1.683 
 
14.03±0.809 
 
 
PCV % 
 
32.2±1.833 
 
40.6±2.689 
 
36.17±4.725 
 
43.1±2.427 
 
 
POLYMORPHS 
(%) 
 
7.333±0.6667 
 
10±1 
 
8±3.055 
 
7±1.155 
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LYMPHOCYTES 
(%) 
 
85.33±2.028 
 
81.33±1.856 
 
79.33±3.528 
 
85.67±2.963 
 
 
MONOCYTES 
(%) 
 
5±0.5774 
 
3±0.5774 
 
3.333±0.6667 
 
3.333±0.3333 
 
 
EOSINOPHILS 
(%) 
 
3.333±0.3333 
 
4.333±0.3333 
 
4.667±0.8819 
 
4.333±0.3333 
 
 
MCH (Pg) 
 
23.6±0.611 
 
24.93±0.4702 
 
24.83±0.6566 
 
25.77±0.3283 
 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by 
one way ANOVA followed by dunnett’s(N=10); p>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group.  
Table No. 11: Effect of 28 days repeated dose of Rasa Karpoora Kuligai 
 On Biochemical parameters 
GROUP CONTROL RKK. LOW 
DOSE 
230mg/kg 
RKK.MID 
DOSE 
450mg/kg 
RKK. HIGH 
DOSE 
600mg/kg 
SGOT(IU/ml) 97.2±6.835 116.1±11.08 98.37±10.16 91.5±3.523 
SGPT (IU/ml) 44.77±8.151 90.73±17.71 45.3±5.852 48.6±6.012 
ALP (IU/ml) 210.1±69.74 
 
175.9±11.87 
 
169.9±27.35 
 
186.6±24.95 
 
TOTAL BILIRUBIN 
(mg/dl 1.303±0.2452 1.453±0.2822 0.8193±0.3371 0.99±0.194 
CREATININE (mg/dl) 0.6133±0.038
44 
 
0.58±0.08327 
 
0.4767±0.0441 
 
0.5867±0.020
28 
 
URIC ACID (mg/dl) 
 
1.747±0.2761 
 
1.74±0.155 
 
2.06±0.6612 
 
1.983±0.2924 
 
 
Values are expressed as mean ± SEM Statistical significance (p) calculated by 
one way ANOVA followed by dunnett’s(N=10); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groups with control group. 
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Table  No: 12  Effect of 28 days repeated dose of Rasa Karpoora Kuligai on  
food intake in grams 
GROUP CONTROL 
RKK. LOW 
DOSE 
230mg/kg 
RKK.MID 
DOSE 
450mg/kg 
RKK. HIGH 
DOSE 
600mg/kg 
1
st 
DAY 42±4.53137 38±4.64758 54.6667±6.23253 40.6667±4.20053 
7
th 
DAY 35.1667±4.13454 39±6.90411 44.5±3.30404 60.6667±7.82588 
14
th 
DAY 42±4.14729 42.6667±5.92546 47±7.49667 47.3333±8.40106 
21
st  
DAY 52±5.83095 41.1667±6.5341 42.6667±9.04311 34.6667±5.71936 
28
th
  DAY 50.5±4.62421 47.3333±6.27517 37.3333±5.3831 42.1667±6.42089 
 
              Values are expressed as mean ± SEM Statistical significance (p) calculated 
by one way ANOVA followed by dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated group swith control group. 
 
 
Table No. 13 : Effect of 28 days repeated dose of Rasa Karpoora Kuligai 
 On Water Intake in ml 
GROUP CONTROL RKK. LOW 
DOSE 
230mg/kg 
RKK.MID 
DOSE 
450mg/kg 
RKK. HIGH 
DOSE 
600mg/kg 
1
st 
DAY 98.3333±13.5195 89.1667±14.3421 102.5±21.6699 67.5±7.6103 
7
th 
DAY 82.5±11.7438 100.833±12.6765 76.6667±9.80363 81.6667±14.4145 
14
th 
DAY 58.3333±8.72417 90.8333±14.2838 80±13.9642 89.1667±8.88976 
21
st  
DAY 91.6667±12.4944 80±8.46562 65.8333±9.43545 89.1667±8.79552 
28
th
  DAY 82.5±11.3835 88.3333±11.4504 75±8.85061 65±7.52773 
 
Values arae expressed as mean ± SEM Statisticalsignificance (p) calculated 
by one way ANOVA followed by dunnett’s(n=6); nsp>0.05, *p<0.05, **p<0.01, 
***p<0.001, calculated by comparing treated groupswith control group. 
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Table No: 14 : Effect of 28 days repeated dose of Rasa Karpoora Kuligai 
 On Electrolytes 
 
       Values arae expressed as mean ± SEM Statistical significance (p) calculated by 
one way ANOVA followed by dunnett’s (n=6); NS- non significant, *p<0.05, 
**p<0.01, ***p<0.001, calculated by comparing treated groups with control group.  
 
Clinical Signs: 
All animals in this study were free of toxic clinical signs throughout the 
dosing   period of 28 days. 
Mortality: 
All animals in control and in all the treated dose groups survived throughout 
the dosing period of 28 days. 
Body weight: 
Results of body weight determination of animals Table No: 8 from control and 
different dose groups exhibited comparable body weight gain throughout the dosing 
period of 28 days. 
Food consumption: 
During dosing and the post-dosing recovery period, the quantity of food 
consumed by animals from different dose groups was found to be comparable with 
that by control animals. 
 
GROUP CONTROL RKK. LOW 
DOSE 230mg/kg 
RKK.MID DOSE 
450mg/kg 
RKK. HIGH 
DOSE 600mg/kg 
Sodium (mg/dl) 4.5±0.6455 4.25±0.6292 6±0.7071 6.75±0.75 
Calcium (mg/dl) 1.575±0.137689 3.15±0.170783*** 4.2±0.163299*** 6.175±0.19311*** 
Phosphorus (U/L) 0.273±0.022517 0.3005±0.019615
ns 
0.35625±0.030491
ns 
5.033±0.32452* 
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Organ Weight: 
Group Mean Relative Organ Weights (%of body weight) are recorded in Table 
No.9 Comparison of organ weights of treated animals with respective control animals 
on day 29 was found to be comparable similarly. 
Hematological investigations: 
The results of hematological investigations (Table No:10) conducted on day 
29 revealed following significant changes in the values of different parameters 
investigated when compared with those of respective controls; however, the increase 
or decrease in the values obtained was within normal biological and laboratory limits 
or the effect was not dose dependent. 
Biochemical Investigations: 
Results of Biochemical investigations conducted on days 29 and recorded in 
Table. No: 11 revealed the following significant changes in the values of hepatic 
serum enzymes studied. When compared with those of respective control. However, 
the increase or decrease in the values obtained was within normal biological and 
laboratory limits. 
Histopathology: 
In histopathological examination, revealed normal architecture in comparison 
with control and treated animal. 
        1)  All the animals from control and all the treated dose groups up to 600 mg/kg 
survived throughout the dosing period of 28 days. 
        2)  No signs of toxicity were observed in animals from different dose groups 
during the dosing period of 28 days. 
         3)  Animals from all the treated dose groups exhibited comparable body weight 
gain with that of controls throughout the dosing period of 28 days. 
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         4)  Food consumption of control and treated animals was found to be 
comparable throughout the dosing period of 28 days 
         5)   Haematological analysis conducted at the end of the dosing period on day 
29, revealed no abnormalities attributable to the treatment. 
          6) Biochemical analysis conducted at the end of the dosing period on day 29 no 
abnormalities attributable to the treatment. 
          7) Organ weight data of animals sacrificed at the end of the dosing period was 
found to be comparable with that of respective controls. 
          8) Histopathological examination revealed normal architecture in comparison 
with control and treated animal. 
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Histopathology of Brain  
 
          
      Plate A : Control Male      Plate B : Control Female 
          
      Plate C : High Dose Male    Plate D : High Dose Female 
 
Plate A: Regular marginal alignment on the neurons with promising histology was 
observed. 
Plate B: The CA zones of brain hippocampi are filled with densely packed Pyramidal 
cells. 
Plate C: Arrangement of neurons on cerebral cortex appears normal and dense. 
Plate D: Three layers of cerebellar cortex, the molecular, purkinje and granular 
layers, appeared clear and distinct without any changes in  their cells 
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Histopathology of Heart 
      
          Plate A : Control Male     Plate B : Control Female 
     
        Plate C : High Dose Male    Plate D : High Dose Female 
 
Plate A: Nucleus appears prominent with regular arrangement of fibres. No evidence 
of pyknotic nucleus. 
Plate B: Myocardial cells appears normal with well-defined mycoplasma and 
prominent nucleus and nucleolus. 
Plate C: Appearance of fibrils and cross striations are normal and equidistant. 
Plate D: Appearance of cardiac myocyte was normal. 
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                                         Histopathology of Lung  
          
         Plate A : Control Male           Plate B : Control Female 
         
      Plate C : High Dose Male    Plate D : High Dose Female 
Plate A: Arrangement of epithelial and muscular appears normal. 
Plate B: Lung parenchyma appears normal with regular arrangement of alveoli and 
alveolar sac with no signs of lymphocyte infiltration and pulmonary fibrosis. 
Plate C: Perfect network of simple squamous epithelium were observed. Inter 
alveolar septum and alveolar capillary appears normal. 
Plate D: Pneuomocyte and capillary appears normal. 
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Histopathology of Stomach  
 
           
      Plate A : Control Male      Plate B : Control Female 
          
      Plate C : High Dose Male    Plate D : High Dose Female 
Plate A: Lumina of blood vessels appears normal. Appearance of glandular lumen 
was normal 
Plate B: Regular arrangement of muscularis externa and outer longitudinal muscle 
were observed. 
Plate C: Gastric glands including secretary sheath appears normal. 
Plate D: Normal gastric mucosa containing intact gastric gland cells, parietal cells 
which are spherical cell with deeply stained dark nucleus. 
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Histopathology of Liver  
 
          
        Plate A : Control Male      Plate B : Control Female 
         
      Plate C : High Dose Male        Plate D : High Dose Female 
Plate A: Cytoplasm appears normal with widen portal tract.No signs of nodular 
degeneration and cirrhosis. 
Plate B: The walls of the lumen appears normal with no evidence of ischemic 
changes . 
Plate C: Liver parenchyma appears normal with no evidence of necrosis. Rare 
appearance of Kupffer cells with no evidence of phagocytosis in intracytoplasmic 
region. 
Plate D: The centrilobular hepatocytes appears normal with stained cytoplasm. 
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     Histopathology of Kidney 
 
           
          Plate A : Control Male     Plate B : Control Female 
           
      Plate C : High Dose Male    Plate D : High Dose Female 
Plate A: Appearance of central artery and marginal sinus are normal. No 
abnormalities found in lymph node  
Plate B: Appearance of glomerular basement membrane was normal. 
Plate C: Foot processes of podocytes are separated from one another by a regular 
narrow Filtration Slit . 
Plate D: Bowman’s capsule appears normal and surrounded with Proximal 
Convoluted Tubule , Distal Convoluted Tubule  and Collecting Duct. 
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Histopathology of Spleen  
            
        Plate A : Control Male           Plate B : Control Female 
             
      Plate C : High Dose Male    Plate D : High Dose Female 
 
Plate A: Normal renal structure with rounded renal corpuscles formed of the 
Glomerulus. Increased bowman space around glomeruli 
Plate B: Marginal vascular zone radiated in between red and white pulp. Appearance 
of splenic red pulp was normal. 
Plate C: Lymphoid follicles appears normal. 
Plate D: Erythropoietic cells (EP) are scattered throughout the red pulp with increased 
number of megakaryocytes. 
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Histopathology of Testes 
 
              
         Plate A : Control Male             Plate B : High Dose Male 
 
Plate A: Histo cytology of testicular tissue shows well differentiated germ cells with 
respect of spermatogonia includes spermatid and sperm were observed. 
Plate B: Normal sertoli cell aligned properly on the basement membrane with oval 
dome shaped nucleus. 
Histopathology of Uterus  
             
       Plate A : Control Female     Plate B : High Dose Female. 
Plate A: Appearance of endometrium, myometrium and uterine glands was normal. 
Plate B: Endometrial stroma; G, gland; M, myometrium; P, perimetrium; L, lumen 
exhibits normal histological aspect of endometrium and myometrium 
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Histopathology of Ovary  
          
            
      Plate A : Control Female        Plate B : High Dose Female 
Plate A: Follicular cells, cytoplasm and nucleus appear normal. 
Plate B: Corpora lutea , atretic follicles  and interstitial tissue  appears normal. 
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Body weight changes of test animals in 28 days repeated oral toxicity study of 
Rasa Karpoora Kuligai 
 
 
Fig 3 
 
 Fig:4 Organ weight changes in grams of test animals in 28 days repeated oral 
toxicity study of Rasa Karpoora Kuligai 
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 Fig 5: Effect of 28 days repeated dose of Rasa Karpoora Kuligai on 
Haematological parameters 
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Fig: 6 
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Fig 6.1 
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Fig:7 Effect of Subacute toxicity of Rasa Karpoora Kuligai on Biochemical 
parameters 
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Fig- 8:  Effect of 28 days repeated dose of Rasa Karpoora Kuligai on  
food intake in grams 
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Fig -9 :  Effect of 28 days repeated dose of Rasa Karpoora Kuligai on  
Water intake in ml 
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6. SUMMARY 
 
The test drug Rasa Karpoora Kuligai is selected from the text, Gunapadam 
Thathu  Jeevam for the evaluation of safety, efficacy and therapeutic potency. 
Aim of the dissertation is to study the toxicity of the test drug Rasa Karpoora 
Kuligai by universal accepted scientific methods. 
The review of the literatures and scientific research reveals  pepper, garlic, 
betel leaf, mother milk  that, are having anti cancer, anti-oxidant, anti-inflammatory 
activities. 
The test drug was prepared properly by the given procedure all the ingredients 
were identified and authenticated by the concerned departments.  
The preparation of trial drug was standardized primarily by physicochemical 
and biochemical analysis   
The physicochemical analysis the drug shows brown in colour with pleasant 
odour and bitter mixed light pungent in taste. 
In physiochemical analysis the total Ash value of test drug is 6.87 which 
shows the total inorganic content (ammonium, potassium, calcium, chloride, iron) 
present in the drug. These contents are having important role in physiological 
functions of the body. 
              Biochemical analysis shows the presence of calcium, sulphate, chloride,  
starch, phosphate, ferrous iron these compounds are protect the body from the risk of   
cancer. 
In instrumental analysis the ICP-OES result shows the  toxic heavy metals 
such as  As, Hg,  Cd, Pb, Al, Cu, Ni  are in Below Detection Limit(BDL)   . The main 
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ingredient of the drug is mercuric II chloride, but the final product RKK shows below 
detection limit of the mercury.  
                
              SEM analysis of the Rasa karpoora kuligai shows that the uniform 
distribution of particles presents in the entire field. Most of the particles present in the 
sample is nano size and near nano size, average particle size is 4.64µm - 7.51µm 
which increase the efficacy and bio availability of the test drug.   
The acute toxicity study shows that Rasa Karpoora Kuligai did not produce 
any toxic effect at dose of 300mg/kg, and 2000 mg/kg to rats. So No-Observed-
Adverse-Effect-Level (NOAEL) of Rasa karpoora kuligai is above 2000mg/kg.Bw.  
In sub acute toxicity study test drug Rasa Karpoora Kuligai can be considered 
safe, as it did not cause either any lethality or adverse changes with general behaviour 
of rats and also there were no observable detrimental effects (230 ,450 &  600 mg/kg 
body weight) over a period of 28 days.  These results have demonstrated that the 
Rasa Karpoora Kuligai  is relatively safe when administered orally in rats. 
In organs of control group and drug treated groups no abnormality was 
detected. Histopathological examination revealed normal architecture in comparison 
with control and treated animal. 
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7. CONCLUSION 
             From the results of analytical evaluation of the test drug Rasa Karpoora 
Kuligai, it is inferred that quality and stability was good when prepared under the 
standard protocol mentioned in this study. Qualitative analysis of RKK reveals the 
purity and bioavailability of the drug. As heavy metals were found to be with in the 
permissible limit so the drug is safe for oral consumption. The particle size of the test 
drug was determined by SEM analysis. In vivo toxicity study reveals the drug RKK 
shows no mortality and signs of toxicity upto 2000 mg/Kg bodyweight in acute oral 
administration. In 28 days repeated oral toxicity study there was significantly changes 
in haematological, biochemical parameter in RKK (230mg, 450mg &600mg /Kg 
bodyweight) treated group but the levels were with in physiological limits. The 
histopathology report also confirms that there are no remarkable cellular changes at 
all the dose level. Based on the results, it can be concluded that, the dose level of  
Rasa Karpoora Kuligai  is  sundai alavu (0.798mg) mentioned in Gunapadam Thathu 
Jeevam is a safe dosage for human consumption.  
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